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Abstract
Solvation Thermodynamic Mapping in Computer-Aided Drug Design
by: Steven Ramsey
Adviser: Thomas Kurtzman
The displacement of water from surfaces upon biomolecular recognition and association makes
a significant contribution to the free energy changes of these processes. We therefore posit that
accurate characterization of local structural and thermodynamic molecular water properties can
improve computational model accuracy and predictivity of recognition and association
processes. In this thesis, we discuss Solvation Thermodynamic Mapping (STM) methods that we
have developed using inhomogeneous fluid solvation theory (IST) to better characterize active
site water structural and thermodynamic properties on protein surfaces and the open source
tools that we have developed, GIST-CPPTRAJ and SSTMap, which implement these methods
which we have distributed to both the academic and industrial scientific community. These
methods include a nearest neighbor approximation for water entropies, a significant
improvement over previous entropy formulations. We then discuss our application of these tools
to the rational modification of (-)-stepholidine, a lead compound for human dopamine receptor
3 (D3R), which led to a handful of promising analogues. Finally, we describe a new method of
creating pharmacophores from solvation thermodynamic maps applied retrospectively to 7
protein targets. The results documented here demonstrate promising applications of STM
methods for prospective drug design. In our conclusions, we discuss potential improvements to
the molecular modeling work with the goal of improving accuracy of predictions in prospective
drug design projects.
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Chapter 1 – Water in Computer-Aided Drug Design
(Introduction)
1.1 Receptor Ligand Signal Transduction
Signal transduction is an important process of cellular life whereby chemical and physical signals are
transmitted through a series of molecular reactions often resulting in cellular responses. Transduction is
typically triggered by a natural substrate - frequently a small molecule ligand – binding to a receptor
protein. The substrate binds to the active site of the receptor to form a protein-ligand complex that elicits
either a physical or chemical response in either the ligand, receptor, or leads to the release of a new ligand
substrate repeating the process in a signal cascade (Figure 1). Most signal transduction processes involve
G-protein coupled receptors, ligand-gated ion channels, cell surface receptors, or receptor tyrosine
kinases1–3. The activation of these receptor types comprises the majority of cell signaling that elicit various
physiological responses such as pain, hunger, emotions, or signal cascades that can produce more
complex responses such as cellular growth regulation, cell reproduction, and programmed cell death
(apoptosis)4.

Figure 1. Schematic of signal transduction activated via ligand-receptor binding. In this example, a membraneembedded receptor receives an extracellular ligand signal and releases an intracellular ligand that leads to a signal
cascade within the cell.
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A good portion of modern industrial drug development leverages the behavior of receptor-ligand signal
transduction to effect a desired biological response. This is accomplished by developing small molecule
drugs that out-compete natural substrates binding to targeted receptors to either inhibit or up-regulate
cellular signal transduction. These small molecule drugs tend to be organic molecules that have other
desirable pharmacokinetic properties such as absorption, distribution, metabolic, excretion, and toxicity
(ADMET). That is to say that a viable small molecule drug can appropriately enter the body or bloodstream
(Absorption), reach the targeted receptor (Distribution) before being metabolized (M) or filtered out
(Excretion) and avoid harmfully affecting other biological processes (Toxicity) before interacting with its
intended target5. Once the molecule reaches the intended target, it must then bind with enough affinity
to elicit the desired biological response. The development of these small molecule compounds is a
complex and difficult endeavor that has led to a multi-billion dollar pharmaceutical industry1 where
receptor targets are identified, small molecule lead compounds are found that bind to said target, are
modified into a bioavailable compound that binds the target with high affinity, specificity, and with the
appropriate ADMET properties, and packaged into a drug commodity oftentimes as an orally ingestible
tablet or pill5.

1.2 Drug Design
The design of small molecule drugs that bind to a receptor target and elicit a desired biological response
are typically developed using a general development pipeline (Figure 2). This development pipeline begins
with the identification of an unwanted biological property, whether it be a pain response or
neurotransmitter signal cascade. Generally, a protein involved in this cascade is identified and it is
validated that its inhibition or up-regulation will affect the desired biological response. After determining
the details of the unwanted biological process, experiments are conducted to identify and solve the
structure of the receptor that is responsible for the unwanted biological property. Upon identifying and

2

characterizing the structural properties of the target receptor, identification of potential lead compounds
that bind the target receptor are found. The identification of lead compounds is typically accomplished by
screening lead compound databases with in-silico or in-vitro assays1. Once lead compounds that bind to
the target receptor are identified an iterative optimization process begins wherein chemical modifications
are made to the lead compound to produce analogs intended to improve the affinity, specificity, and
ADMET properties of the potential small molecule drug5. After a lead compound has been modified into
a small molecule drug that has the desired pharmacokinetic properties in vivo testing begins and
eventually leads to clinical trials and if successful the release of the small molecule drug compound onto
the market as a pharmaceutical therapeutic6. This development process is expensive and failure directly
results in loss of invested research costs7. A fundamental goal of computer-aided drug design (CADD) in
this thesis is to help alleviate these costs by informing drug design decisions. The methods discussed in
this thesis are aimed at expediting the lead identification and lead optimization processes. Further
discussion of CADD can be found in section 1.3.

Figure 2. Schematic describing the drug development process. Drug design begins with target identification,
followed by lead identification where potential small molecule scaffolds that bind the receptor target are found,
lead modification, and finally clinical trials. Computer-aided drug design (discussed further in section 1.3) primarily
occurs in the early stages involving target modeling, lead identification, and lead modification. The described drug
development process typically undergoes heavy iteration, repeating previous steps, and is not as neatly linear as
depicted here.

1.3 Computer Aided Drug Design (CADD)
The steady growth of computing power in the last two decades has led to the incorporation of computers
in the drug design workflow. Computer-aided drug design (CADD) as it’s called offers several tools that
assist in the modeling and understanding of target receptors. Computational tools range from modeling
methods (visualization software, homology models) to robust thermodynamic calculations that can
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further describe or define compound structure activity relationships (SAR). In this way, CADD has grown
to become an integral part of many drug design programs.
Computer-aided drug discovery methods have gained significant traction in the pharmaceutical industry
and are mainly used in the early stages (target identification, lead identification, and lead modification) of
the drug discovery process (Figure 2). These approaches can roughly be divided into empirical approaches
that are informed by statistical analysis of experimental data and physical approaches that are based on
molecular models of the physical system of interest. Our research focuses on improving the treatment of
water in molecular models of protein-ligand interactions. In particular, we focus on how better treatments
of solvation can help improve lead identification through virtual screening and lead optimization. The
fundamental hypothesis of our approach is that more sophisticated treatments of water in the lead
identification and lead optimization stages can improve upon current existing CADD approaches.
In lead identification, virtual screening methods including docking8 , pharmacophores9, and ligand SAR10
are used to discriminate potential binding from non-binding compounds in electronic compound
databases before more costly experimental high throughput screens are performed. Docking methods
explore ligand conformations and poses on a target protein and attempt to quickly assess whether a given
ligand may bind to the target. Pharmacophores are abstract 3-dimensional maps of interactions that are
considered to be essential for binding. These maps are then screened through electronic databases to
identify compounds with similar maps and therefore can potentially bind to the targeted protein.
In rational lead modification molecular modeling allows medicinal chemists to visualize potential ligandreceptor interactions, which informs them as to which chemical modifications to a lead have the potential
to bind with higher affinity. This is illustrated in Figure 3. Descriptions of water help inform this process
since ligands tend to interact with a protein surface in a manner similar to surface water (Figure 3).
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Furthermore, insight into whether a given modification to a ligand will lead to gains in binding affinity can
be informed by the local solvation thermodynamics of displaced water11–14.

Figure 3. Two high energy hydration sites (yellow and green) identified in the secondary binding site of D3R (PDB:
3PBL15) shown with their most probable water configuration extracted from an explicit water MD trajectory and (-)stepholidine, our lead compound, shown in ball and stick. The yellow hydration site represents a displaceable
hydration site with a water molecule that forms a hydrogen bond with a threonine on the protein surface. A potential
modification to (-)-stepholidine that builds a functional group that can form a hydrogen bond to said threonine is
predicted to result in a binding affinity gain. On the right, we show a potential modification at the C9 position that
can replace the hydrogen bond water molecules in the yellow site form with the THR on the protein surface.

1.4 Water on biological surfaces
In the absence of a ligand, biological water occupies all available space within a protein binding site. Upon
the binding of a ligand, which for a successful drug results in a desired effect upon biological signal
transduction, water in the binding site is either displaced to bulk biological water or reorganizes around
the protein-ligand complex often forming bridging hydrogen bonds between the small molecule and the
protein surface (Figure 4). Water structure (related to entropy) and energetics in the bound and unbound
states differ such that the displacement and reorganization of water upon ligand binding has a significant
contribution to the free energy of the process. To minimize its free energy, active-site water adopts a
structure which is complementary to the protein surface; accepting and donating hydrogen bonds to the
protein surface where appropriate and doing neither with hydrophobic protein surfaces. The structure of
5

these water molecules is therefore analogous to an ‘idealized’ small molecule occupying the same space
in the protein active site. In this fashion, the description of water behavior within the protein active site
may provide a map of interactions that can be leveraged during rational lead modification. If a small
molecule can be designed to closely mimic the water structure in a protein active site then upon binding
of said molecule the water in the active site is released back to bulk thereby lowering the systems overall
energy. Further optimization of specific interactions between the small molecule ligand and the protein
can then enhance the overall binding energy. For these reasons, the consideration of active site waters in
drug design has been steadily gaining traction in the CADD community leading to an increased awareness
of the role active site waters play in biomolecular association and several methodologies developed to
map active site waters and characterize their thermodynamic contributions. An overview of these
methodologies will be discussed below in section 1.6.

Figure 4. Schematic of active site water behaviors during the ligand-receptor binding process. Prior to ligand
binding, the receptor (blue Pac man) active site and the ligand are solvated by water molecules (A). Active site water
molecules can be displaced (B), form bridging hydrogen bonds between the ligand and receptor (C), or reorganize
around the resulting ligand-receptor complex (D). These processes have a significant impact on the free energy of
ligand binding and therefore the effectiveness of small molecule drug compounds.

6

1.5 The impact of active site waters on the free energy of ligand binding
The free energy of protein-ligand binding (∆𝐺𝑏𝑖𝑛𝑑 ) can be described by a summation of the free energy
change in intramolecular interactions (∆𝐺𝑖𝑛𝑡𝑟𝑎 ) and intermolecular interactions (∆𝐺𝑖𝑛𝑡𝑒𝑟 ) in the system.
∆𝐺𝑏𝑖𝑛𝑑 = ∆𝐺𝑖𝑛𝑡𝑟𝑎 + ∆𝐺𝑖𝑛𝑡𝑒𝑟

(Eq 1.5.1)

The change in intramolecular free energy depends on the change in internal interaction energy of the
𝑝𝑟𝑜𝑡𝑒𝑖𝑛

𝑙𝑖𝑔𝑎𝑛𝑑

protein (𝐸𝑖𝑛𝑡𝑟𝑎 ) and ligand (𝐸𝑖𝑛𝑡𝑟𝑎 ) upon binding and the change in entropy of the protein (𝑆 𝑝𝑟𝑜𝑡𝑒𝑖𝑛 )
and ligand (𝑆𝑙𝑖𝑔𝑎𝑛𝑑 ).
(Eq 1.5.2)

𝑝𝑟𝑜𝑡𝑒𝑖𝑛

∆𝐺𝑖𝑛𝑡𝑟𝑎 = ∆𝐸𝑖𝑛𝑡𝑟𝑎

𝑙𝑖𝑔𝑎𝑛𝑑

+ ∆𝐸𝑖𝑛𝑡𝑟𝑎 + 𝑇∆𝑆 𝑝𝑟𝑜𝑡𝑒𝑖𝑛 + 𝑇∆𝑆𝑙𝑖𝑔𝑎𝑛𝑑

The change in intramolecular interaction energy for both protein and ligand can be represented as the
difference of intramolecular energy of the bound state from the unbound state.
𝑝𝑟𝑜𝑡𝑒𝑖𝑛

𝑝𝑟𝑜𝑡𝑒𝑖𝑛,𝑏𝑜𝑢𝑛𝑑

(Eq 1.5.3)

∆𝐸𝑖𝑛𝑡𝑟𝑎

(Eq 1.5.4)

∆𝐸𝑖𝑛𝑡𝑟𝑎 = 𝐸𝑖𝑛𝑡𝑟𝑎

𝑙𝑖𝑔𝑎𝑛𝑑

= 𝐸𝑖𝑛𝑡𝑟𝑎

𝑙𝑖𝑔𝑎𝑛𝑑,𝑏𝑜𝑢𝑛𝑑

𝑝𝑟𝑜𝑡𝑒𝑖𝑛,𝑢𝑛𝑏𝑜𝑢𝑛𝑑

− 𝐸𝑖𝑛𝑡𝑟𝑎

𝑙𝑖𝑔𝑎𝑛𝑑,𝑢𝑛𝑏𝑜𝑢𝑛𝑑

− 𝐸𝑖𝑛𝑡𝑟𝑎

For flexible ligands and proteins, the adoption of the appropriate bound state conformations often results
in disrupted intramolecular interactions and in the case of rigid receptors and ligands the change in strain
and intramolecular energy is negligible. In both the flexible and rigid case, the change in intramolecular
energy for both protein and ligand favor the unbound state. Similarly, the change in entropy for both
protein and ligand can be represented as the difference in entropy between the bound and unbound
states.
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(Eq 1.5.5)

∆𝑆 𝑝𝑟𝑜𝑡𝑒𝑖𝑛 = 𝑆 𝑝𝑟𝑜𝑡𝑒𝑖𝑛,𝑏𝑜𝑢𝑛𝑑 − 𝑆 𝑝𝑟𝑜𝑡𝑒𝑖𝑛,𝑢𝑛𝑏𝑜𝑢𝑛𝑑

(Eq 1.5.6)

∆𝑆𝑙𝑖𝑔𝑎𝑛𝑑 = 𝑆𝑙𝑖𝑔𝑎𝑛𝑑,𝑏𝑜𝑢𝑛𝑑 − 𝑆𝑙𝑖𝑔𝑎𝑛𝑑,𝑢𝑛𝑏𝑜𝑢𝑛𝑑

Upon binding both the protein and ligand experience a significantly reduced number of occupiable states
thus resulting in significant entropic penalties. These entropic penalties also favor the unbound state.
The free energy change in intermolecular interactions that contribute to the free energy of protein ligand
binding includes energy terms that account for the intermolecular interactions between protein-ligand
(𝐸𝑝𝑟𝑜𝑡𝑒𝑖𝑛−𝑙𝑖𝑔𝑎𝑛𝑑 ), protein-water (𝐸𝑝𝑟𝑜𝑡𝑒𝑖𝑛−𝑤𝑎𝑡𝑒𝑟 ), ligand-water (𝐸𝑙𝑖𝑔𝑎𝑛𝑑−𝑤𝑎𝑡𝑒𝑟 ), and water-water
(𝐸𝑤𝑎𝑡𝑒𝑟−𝑤𝑎𝑡𝑒𝑟 ) interactions as well as the change in entropy of displacing active site water molecules into
bulk (∆𝑆𝑤𝑎𝑡𝑒𝑟 ).
(Eq 1.5.7)

∆𝐺𝑖𝑛𝑡𝑒𝑟 = ∆𝐸𝑝𝑟𝑜𝑡𝑒𝑖𝑛−𝑙𝑖𝑔𝑎𝑛𝑑 + ∆𝐸𝑝𝑟𝑜𝑡𝑒𝑖𝑛−𝑤𝑎𝑡𝑒𝑟 + ∆𝐸𝑙𝑖𝑔𝑎𝑛𝑑−𝑤𝑎𝑡𝑒𝑟 +
∆𝐸𝑤𝑎𝑡𝑒𝑟−𝑤𝑎𝑡𝑒𝑟 + 𝑇∆𝑆𝑤𝑎𝑡𝑒𝑟

Where the intermolecular change in interaction energy between protein and ligand is the difference in
interaction energy between the bound and unbound states.
(Eq 1.5.8)

𝑏𝑜𝑢𝑛𝑑
𝑢𝑛𝑏𝑜𝑢𝑛𝑑
∆𝐸𝑝𝑟𝑜𝑡𝑒𝑖𝑛−𝑙𝑖𝑔𝑎𝑛𝑑 = 𝐸𝑝𝑟𝑜𝑡𝑒𝑖𝑛−𝑙𝑖𝑔𝑎𝑛𝑑
− 𝐸𝑝𝑟𝑜𝑡𝑒𝑖𝑛−𝑙𝑖𝑔𝑎𝑛𝑑

In the unbound state the protein and ligand are distal of each other in such a manner that the energy of
interaction between the two in the unbound state is negligible. Therefore, the change in intermolecular
energy due to protein-ligand interactions favors the bound state due to the interactions formed in the
resulting protein-ligand complex. This effect is typically considered to be offset by the change in energy
due to protein-water and ligand-water interactions.
(Eq 1.5.9)

𝑏𝑜𝑢𝑛𝑑
𝑢𝑛𝑏𝑜𝑢𝑛𝑑
∆𝐸𝑝𝑟𝑜𝑡𝑒𝑖𝑛−𝑤𝑎𝑡𝑒𝑟 = 𝐸𝑝𝑟𝑜𝑡𝑒𝑖𝑛−𝑤𝑎𝑡𝑒𝑟
− 𝐸𝑝𝑟𝑜𝑡𝑒𝑖𝑛−𝑤𝑎𝑡𝑒𝑟
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(Eq 1.5.10)

𝑏𝑜𝑢𝑛𝑑
𝑢𝑛𝑏𝑜𝑢𝑛𝑑
∆𝐸𝑙𝑖𝑔𝑎𝑛𝑑−𝑤𝑎𝑡𝑒𝑟 = 𝐸𝑙𝑖𝑔𝑎𝑛𝑑−𝑤𝑎𝑡𝑒𝑟
− 𝐸𝑙𝑖𝑔𝑎𝑛𝑑−𝑤𝑎𝑡𝑒𝑟

For both the ligand and protein the formation of a protein-ligand complex disrupts most interactions
formed with solvating water molecules including hydrogen bonds and hydrophobic contacts where
appropriate. These disrupted interactions with water molecules involve a roughly comparable number of
hydrogen bond contacts that would be formed by the resulting protein-ligand complex, these interactions
may not be equivalent, but are opposite in sign to each other, resulting in offset energy terms that often
favors the unbound state. The protein-ligand, protein-water, and ligand-water energetic terms are
thought to be counter-complementary and have a negligible contribution to the free energy of binding
overall (∆𝐺𝑏𝑖𝑛𝑑 ). The remaining terms (equations 1.5.11 and 1.5.12) account for the change in
intermolecular energies between water molecules and the change in water entropy.
(Eq 1.5.11)

𝑏𝑜𝑢𝑛𝑑
𝑢𝑛𝑏𝑜𝑢𝑛𝑑
∆𝐸𝑤𝑎𝑡𝑒𝑟−𝑤𝑎𝑡𝑒𝑟 = 𝐸𝑤𝑎𝑡𝑒𝑟−𝑤𝑎𝑡𝑒𝑟
− 𝐸𝑤𝑎𝑡𝑒𝑟−𝑤𝑎𝑡𝑒𝑟

(Eq 1.5.12)

𝑏𝑜𝑢𝑛𝑑
𝑢𝑛𝑏𝑜𝑢𝑛𝑑
−𝑇∆𝑆𝑤𝑎𝑡𝑒𝑟 = −𝑇(𝑆𝑤𝑎𝑡𝑒𝑟
− 𝑆𝑤𝑎𝑡𝑒𝑟
)

These thermodynamic terms are the heart of the hydrophobic effect and have no counter-complementary
terms. In the case of energy, water molecules form complementary interactions with the protein surface
in the unbound state as well as neighboring water molecules in bulk in the bound state. Generally, water
molecules on solute surfaces experience a reduction in the number of hydrogen bond interactions formed
relative to bulk (the unbound state for water molecules), which results in ∆𝐸𝑤𝑎𝑡𝑒𝑟−𝑤𝑎𝑡𝑒𝑟 to favor the
bound state. In a similar fashion the water molecules in the unbound state adopt constrained
conformations around the protein and ligand surfaces resulting in low entropies. In the bound state these
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water molecules are displaced to bulk, which has fixed entropy, leading to the bound state being favored
by this term as well.
Overall, the intramolecular interactions have a minor, but important contribution to the free energy of
binding and the intermolecular interactions formed by the protein and ligand are counter-complementary
between the bound and unbound state. Therefore, the main thermodynamic contribution to the free
energy of binding can be found in the terms accounting for the energy and entropy of water
(∆𝐸𝑤𝑎𝑡𝑒𝑟−𝑤𝑎𝑡𝑒𝑟 and 𝑇∆𝑆𝑤𝑎𝑡𝑒𝑟 ). The methods described in this thesis aim to accurately quantify these
thermodynamic contributions and to characterize this contribution in solvation thermodynamic mapping
methods that can be used to improve existing computer-aided drug design methods.

1.6 Solvation Thermodynamic Mapping
The importance of active site water molecules in protein-ligand binding and therefore drug design has led
to increased research focus in recent years on active site waters16. This can be seen in Figure 5, where we
show that the number of publications that contain the keywords "water molecules" and "protein binding
site" together has been growing rapidly since the early 2000's, only recently dropping off slightly. The peak
popularity of this literature search coincides nicely with the few years that proceeded the literature
publication of a solvation thermodynamic mapping method that led to the eventual production and
release of WaterMap described by Young et al.11,12 Prior to the discussion of these results and their success
in explaining retrospective SAR data the consideration of water in computational modeling of drug targets
tended to be mostly ignored in favor of docking studies and molecular dynamics simulations. After the
success and release of WaterMap, several novel STM methods were developed with the intent to map
active site water thermodynamics using a variety of techniques. The application of solvation
thermodynamic mapping in drug discovery projects has shown promise in identifying ‘hot-spots’, regions
that when a small molecule ligand binds to may result in large gains in binding affinity and has been utilized
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to interpret retrospective structure activity relationships (SAR) that could not be rationalized without
considering active site waters.

Number of Publications
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Figure 5. Google scholar literature search of studies featuring the keywords "water molecules" and "protein binding
sites" over the last few decades. The population of these studies has been steadily increasing and recently has begun
to drop. A literature search performed with Google Scholar through the City University of New York library proxy, as
analyzed in a previous review by Bodnardchuk16, information accessed on November 9th 2016.

The mapping of active site waters and characterization of thermodynamic properties referred to hereafter
as solvation thermodynamic mapping (STM). The mapping of active site waters can be accomplished
typically through the sampling of explicit water molecules in molecular dynamics simulations or the
sampling of density distributions produced by implicit solvent fields. The enthalpy of interactions
experienced by these mapped waters can be determined using the Lennard Jones and electrostatic
parameters applied in the constructed model by summing up all interactions between a water molecule
at a given position and the rest of the modeled system. The entropy of water on biological surfaces
presents a unique problem that cannot be solved directly through the pre-allocated force field parameters
of atoms in the simulation system. Entropies are determined by assessing the order of molecules over
time such that the relative rigidity of molecules can be determined. Most studies focusing on the entropy
of fluids did so in a bulk environment using hard body fluids such as liquid Argon17–19 to derive formulae
that described the entropy of a given molecule in solution. These derivations were then extrapolated to
solvents with more complexity such as water20–22.
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We describe the entropy of water molecules in the STM methods applied in the following studies using
Inhomogeneous Solvation Theory (IST) described by Lazaridis et al17–22. This theory applies an expansion
of orientational and spatial particle correlation functions to calculate entropy. In this framework, a
uniform bulk water distribution has an entropy of zero and local ordering due to the presence of the
protein results in unfavorable entropy. The entropies calculated in the works reported here were
determined using a full numerical evaluation of the first term in the N-body expansion while
approximating higher order terms to be negligible. Second order terms are known to contribute
significantly to an active site water molecule's total entropy, however, this term is not evaluated in these
studies due to technical challenges. The first order entropic penalty can be summarized as Shannon
entropy:
(Eq 1.6.1)

𝑆𝑠𝑤 = −

𝑘𝑏 𝜌°
∫ 𝑔𝑠𝑤 (𝒓, 𝝎)𝑙𝑛𝑔𝑠𝑤 (𝒓, 𝝎) 𝑑𝒓𝑑𝝎
8𝜋2

Where 𝑘𝑏 is Boltzmann’s constant, 𝜌° is bulk number density of water for the water model in use, and
𝑔𝑠𝑤 (𝒓, 𝝎) is the single-body distribution of water at a given position 𝒓 and orientation 𝝎. In the following
studies, this formulation is applied within the framework of Hydration Site Analysis, an STM method that
maps solvent structural and thermodynamic properties to discrete sites, and Grid Inhomogeneous
Solvation Theory (GIST), an STM method that maps solvent structural and thermodynamic properties to
a high-resolution grid of arbitrary resolution.

1.7 Outline of Thesis
This thesis is organized as follows. Chapter two discusses the previously existing Solvation Thermodynamic
Mapping (STM) methods for characterizing active site water properties including a description of the
improved nearest neighbor formulation of solvent entropies in Chapter 3. Chapter 4 continues with a
discussion of software development we have done particularly the development of grid inhomogeneous
solvation theory (GIST) into the public codebase AmberTools and SSTMap.13,23–25 This chapter concludes
with a brief mention of software packages we have developed and released that incorporate these tools
12

in an updated codebase. Chapter 5 discusses our applications of STM methods to computer-aided drug
design projects. These applications were done in close collaboration with Dr. Wayne Harding at Hunter
College, Dr. Ian Alberts at La Guardia Community College, and Dr. Art Cho at Korea University and describe
two applications of STM approaches. The first in collaboration with both Dr. Wayne Harding and Dr. Ian
Alberts involves the implementation of STM information in the rational lead modification of (-)Stepholidine an antagonist for human dopamine receptor 3 (D3R)26,27. The second project in collaboration
with Dr. Art Cho describes the implementation of STM information into a Water Based Pharmacophore
selection criteria28 that enable the virtual screening of compound databases in the absence of known
binder information.
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Chapter 2 – Solvation Thermodynamic Mapping Methods
The first application of solvation thermodynamic mapping on relevant drug targets was performed by
Young et al. on Streptavadin (PDB: 1STP)11,29. This study developed a novel methodology that sampled
water configurations from explicit water molecular dynamics simulations and mapped structural and
thermodynamic properties onto discrete hydration sites identified through a clustering algorithm. The
hydration sites characterized by this method at the active site surface of streptavidin describe the
enthalpy, entropy, and free energy of water at those discrete locations. This enabled an in-depth analysis
of the displacement of water from the active site surface by a small molecule ligand. This STM
methodology was eventually developed further into software licensed by Schrodinger LLC named
WaterMap11,12 and remains a widely applied solvation thermodynamic mapping approach in the
pharmaceutical industry. In this chapter we begin by discussing how inhomogeneous solvation theory is
applied in solvation thermodynamic mapping methods below. We then discuss the improvements we
made to STM of first order entropies using a nearest neighbor approximation in chapter 3, and describe
our STM software development contributions in Chapter 4.

2.1 Inhomogeneous Fluid Solvation Theory Methods
Methods that apply inhomogeneous solvation theory (IST)20,21 assess the thermodynamic and structural
properties of water on solute surfaces by sampling water configurations from explicit water molecular
dynamics simulations. These sampled water configurations are used to characterize and map
thermodynamics properties of water molecules, particularly energy (equation 2.1.1) and entropy
(equation 2.1.2).
(Eq 2.1.1)

°
° 2
𝑖𝑛ℎ
𝐸𝑡𝑜𝑡 = 𝐸𝑠𝑤 + 𝐸𝑤𝑤 = 𝜌𝑤
−
) ∫ 𝑔𝑠𝑤 (𝒓)[𝑔𝑠𝑤 (𝒓′ )𝑔𝑤𝑤
∫ 𝑔𝑠𝑤 𝜇𝑠𝑤 𝑑𝒓 + 1⁄2 (𝜌𝑤
°
′
𝑔𝑤𝑤 ]𝜇𝑤𝑤 𝑑𝒓𝑑𝒓
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(Eq 2.1.2)

𝑆𝑡𝑜𝑡 = 𝑆𝑠𝑤 + 𝑆𝑤𝑤
= −𝑘𝜌𝑤 ° ∫ 𝑔𝑠𝑤 (𝒓)𝑙𝑛𝑔𝑠𝑤 (𝒓)𝑑𝒓
2

°
𝑖𝑛ℎ
𝑖𝑛ℎ
𝑖𝑛ℎ
− 1⁄2 𝑘(𝜌𝑤
𝑙𝑛𝑔𝑤𝑤
− 𝑔𝑤𝑤
+ 1}
) ∫ 𝑔𝑠𝑤 (𝒓)[𝑔𝑠𝑤 (𝒓′ ){𝑔𝑤𝑤
°
°
°
− {𝑔𝑤𝑤
𝑙𝑛𝑔𝑤𝑤
− 𝑔𝑤𝑤
+ 1}]𝑑𝒓𝑑𝒓′

Where 𝐸𝑠𝑤 is the energy of interaction between solute and water, 𝐸𝑤𝑤 is the energy of interaction
°
between water molecules, 𝜌𝑤
is the number density of bulk water, 𝑔𝑠𝑤 is the grand canonical pair

correlation function pair correlation function, 𝑔𝑠𝑤 (𝒓) is the number density of water in units of bulk
°
𝑖𝑛ℎ
density, 𝑔𝑤𝑤
is the bulk pair correlation function, 𝜇 is the interaction potential, and 𝑔𝑤𝑤
is the pair

correlation function in the inhomogeneous environment.
The description of solvent entropy is complete as an infinite series and is a combination of 𝑆𝑠𝑤 (equation
2.1.3) and 𝑆𝑤𝑤 (equation 2.1.4) terms.
(Eq 2.1.3)

𝑆𝑠𝑤 = −𝑘𝜌𝑤 ° ∫ 𝑔𝑠𝑤 𝑙𝑛𝑔𝑠𝑤 𝑑𝒓

(Eq 2.1.4)

° )
𝑖𝑛ℎ 𝑙𝑛𝑔𝑖𝑛ℎ − 𝑔𝑖𝑛ℎ + 1} − {𝑔° 𝑙𝑛𝑔°
°
′
𝑆𝑤𝑤 = − 1⁄2 𝑘(𝜌𝑤
∫ 𝑔𝑠𝑤 (𝒓)[𝑔𝑠𝑤 (𝒓′ ){𝑔𝑤𝑤
𝑤𝑤
𝑤𝑤
𝑤𝑤
𝑤𝑤 − 𝑔𝑤𝑤 + 1}]𝑑𝒓𝑑𝒓
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Equation 2.1.3 describes the ordering of water molecules due to the presence of the solute (protein) and
equation 2.1.4 describes the correlational entropy dependent on other water molecules. In most
applications of IST for mapping water entropies the 𝑆𝑤𝑤 term (equation 2.1.4) are large but ignored due
to technical challenges and therefore most methods apply only a 1st order estimate of entropy (𝑆𝑠𝑤 ,
equation 2.1.3). In most applications of STM the mapped water properties are compared to bulk water
conditions where bulk energy (𝐸𝑤𝑤,𝑏𝑢𝑙𝑘 ) is based on the water model in use and bulk entropy (𝑆𝑠𝑤,𝑏𝑢𝑙𝑘 )
is zero by definition.
(Eq 2.1.5)

∆𝐸𝑑𝑖𝑠𝑝𝑙𝑎𝑐𝑒 = 𝐸𝑡𝑜𝑡 − 𝐸𝑡𝑜𝑡,𝑏𝑢𝑙𝑘

(Eq 2.1.6)

∆𝑆𝑑𝑖𝑠𝑝𝑙𝑎𝑐𝑒 = 𝑆𝑡𝑜𝑡 − 𝑆𝑡𝑜𝑡,𝑏𝑢𝑙𝑘
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By referencing bulk conditions, STM with IST enables the estimation of thermodynamics of water
displacement during ligand binding based on an initial state approximation of water properties at the
protein active site.
This IST based STM methodology has been applied in techniques such as WaterMap11,12, Hydration Site
Analysis30, WatSite31, and WatClust32. These methods provide an accurate and intuitive characterization
of high-density hydration sites on the solute surface using density-based clustering. In addition
WaterMap11,12, Hydration Site Analysis, WatSite31, and WatClust32 each benefit from their

incorporation into intuitive graphical user interfaces in Maestro, PyMol33, and VMD34 respectively,
allowing end-users to navigate their use in STM with visual cues. These methods provide structural and
thermodynamic properties of water molecules on protein surfaces in an intuitive description, however,
they do require potentially costly molecular dynamics simulations unlike other methods that rely on
implicit solvation35–37.
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Chapter 3 – Nearest Neighbor Approximation for Solvent
Entropies
We developed and incorporated of an improved formulation for calculating first order IST entropy of
water molecules in STM through a nearest neighbor approximation38. In earlier implementations of
IST11,12,20 the first order entropy is solved using a histogram approach (here shown for a voxel 𝑘):
(Eq 3.1)

𝑡𝑟𝑎𝑛𝑠 (𝒓 )
°
∆𝑆𝑠𝑤
𝑘 ≡ −𝑘𝐵 𝜌 ∫ 𝑔(𝒓)𝑙𝑛𝑔(𝒓)𝑑𝒓

(Eq 3.2)

≈ 𝑘𝐵 𝜌° 𝑉𝑘 𝑔(𝒓𝑘 )𝑙𝑛𝑔(𝒓𝑘 )

(Eq 3.3)

𝑔(𝒓𝑘 ) ≡ 𝜌° 𝑉 𝑘𝑁

𝑁

𝑘 𝑓

Where 𝑘𝐵 is the Boltzmann constant, 𝑔(𝒓) is the number density of water molecules at a given position
𝒓 in units of bulk density, 𝜌° is the number density of bulk water, 𝑁𝑘 is the number of water molecules
sampled in voxel 𝑘, 𝑉𝑘 is the volume of voxel 𝑘, and 𝑁𝑓 is the number of frames sampled in a trajectory.
This treatment evaluates the Shannon entropy in equation 3.1 directly by counting the number of water
molecules found in that mapped location and solving for 𝑔(𝒓𝑘 ) in equation 3.3. This histogram approach
is intuitive but treats the density distribution as uniform over the histogram region resulting in a
significantly biased high entropy39,40. The entropy of the system can be described by an integral over the
volume of the system:
(Eq 3.4)

𝑆𝑠𝑦𝑠 = ∫ 𝑔(𝒓)𝑙𝑛𝑔(𝒓)𝑑𝒓
𝑣𝑜𝑙

Recently, an improved approximation for the Shannon entropy in equation 3.4 has been shown known
as the nearest neighbor approximation that we applied on a per voxel basis by summing over all water
molecules found in each voxel 𝑘41.
(Eq 3.5)

𝑁

𝑘
𝑆𝑣𝑜𝑥 = ∫𝑘 𝑔𝑠𝑤 (𝒓)𝑙𝑛𝑔𝑠𝑤 (𝒓)𝑑𝒓 ≈ ∑𝑖=1
𝑙𝑛𝑔𝑛𝑛 (𝒓) + 𝛾

This approximation estimates the Shannon entropy by calculating the volume of a sphere (𝑉𝑛𝑛 ) whose
radius is equivalent to the shortest distance between two water molecules (𝑑𝑛𝑛 ):
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(Eq 3.6)

𝑔𝑛𝑛 (𝒓) =

(Eq 3.7)

𝑉𝑛𝑛 =

1
𝜌° 𝑉𝑛𝑛

3
4𝜋𝑑𝑛𝑛
3

This nearest neighbor approximation provides an entropy estimate with improved accuracy. To validate
said accuracy improvements we performed an in-silico experiment wherein we took a bulk system of
water molecules from an explicit water molecular dynamics trajectory reduced the volume of the system
while maintaining the number of water molecules sampled. This experiment intends to measure the
biased entropy due to reducing the system volume by half (Figure 6) or a quarter, which has a known
relationship:

Figure 6. In silico system of water molecules biased to reduced volumes where each point represents the location
of a water molecule centered on their oxygen atom position. In A, we show the full system analyzed (a sphere of
water molecules with a 5 Å radius) and in B we show the biased system at half volume which contains an equivalent
number of water molecules.

(Eq 3.8)

𝑉

∆𝑆 = 𝑘𝐵 𝑇𝑙𝑛(𝑉2 )
1

Where 𝑉2 is the final volume of the system and 𝑉1 is the initial volume of the system. The entropy of an
ideal system whose volume has been halved can be exactly calculated, in units of kcal per mol: -0.4132
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(kcal/mol) and -0.8265 (kcal/mol) for a system whose volume has been quartered. We evaluated the
average difference in entropy of water between the full system, biased system with half volume, and
biased system with quarter volume at 10, 20, and 40 ns respectively (Figures 7 and 8).
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Figure 7. Comparison of entropy convergence of a biased system with half volume between the histogram method
(blue) and nearest-neighbor method (orange). The known result for biasing a bulk system to half volume is -0.4132
(kcal/mol) represented in gray.
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Figure 8. Comparison of entropy convergence of a biased system with quarter volume between the histogram
method (blue) and nearest-neighbor method (orange). The known result for biasing a bulk system to half volume is
-0.8265 (kcal/mol) represented in gray.
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In both cases the entropy estimate produced by the histogram method for these biased volume systems
underestimated the entropy by roughly a factor of 2, whereas the nearest neighbor entropy converged to
the expected value to within a few significant digits. We incorporated the nearest neighbor approximation
for entropy in both hydration site analysis and GIST (as discussed in section 4.1) to improve the
convergence and accuracy of solvent entropies. In GIST we also performed a combined entropy analysis
wherein a nearest neighbor approximation was performed on a six-dimensional space where translations
and orientations are combined (section 4.1).
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Chapter 4 – Software Development Contributions
In this section we describe the software developed over the course of this thesis. These developments
include the incorporation of GIST into the AmberTools package CPPTRAJ (section 4.1), the development
of solvation structure and thermodynamic mapping (SSTMap, section 4.2) a software package with
compatibility with multiple molecular dynamics packages, the development of GIST post-processing
(GISTPP, section 4.3) – a software package designed to enable end-users to manipulate the data produced
by GIST, and BiggerGist (section 4.4), a protocol designed to massively parallelize GIST calculations such
that large regions of interest (i.e. full protein surfaces) become computationally tractable with calculations
performed in parallel.

4.1 GIST-CPPTRAJ
Here we describe our development of software that implements GIST into the AmberTools package
CPPTRAJ38. As mentioned above GIST is a methodology that applies IST formulations for mapping solvent
properties onto a space-filling, high-resolution, 3-dimensional gridded region of interest. The initial
formulation of the methodology was tested in a previous study13 and was developed further by
incorporating an improved method of calculation for first order entropy using a nearest neighbor
approximation, described further in the above methodology development chapter 2. CPPTRAJ is the
primary software package for post processing MD trajectories in the AMBERMD package and therefore
the implementation of GIST into this package makes it available to a large community of computational
chemists.
We begin with an overview of GIST-CPPTRAJ, then describe the algorithms utilized in GIST-CPPTRAJ,
demonstrate convergence properties of the thermodynamic quantities evaluated by GIST-CPPTRAJ,
describe the application of GIST in an end-states analysis, and finally conclude.
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4.1.1 Overview of GIST-cpptraj and GISTPP
GIST-cpptraj is a straightforward, command-line tool, included within CPPTRAJ23, which analyzes
molecular dynamics trajectories and maps out the structural and thermodynamic quantities of water in a
user-defined region of interest. This region is partitioned into a high-resolution, three-dimensional (3D)
grid (Figure 9), each grid box of which may be viewed as a voxel, a three-dimensional volume element.
The grid’s desired size, position, and resolution (i.e. the size of the voxels) are specified via the command
line, as detailed in Table 1. Thermodynamic quantities are calculated and mapped to each voxel via the
grid based implementation of IST.13 In addition, a variety of local measures of solvent structure are
calculated for the water in each voxel. The thermodynamic and structural properties of water are listed
in Table 2.
By default GIST outputs thermodynamic quantities from Table 2 in Data Explorer (.dx) file format, enabling
visualization with standard graphics packages, such as VMD and PyMol.33,34 Thermodynamic quantities in
per water units are not output in the dx file, but are accessible through the space-delimited text output
file that includes all calculated quantities. The GIST post-processing suite of tools, GISTPP, further aids in
the analysis of GIST outputs by supporting an array of mathematical and logical operations on .dx files.
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Figure 9. Co-crystal structure of Coagulation Factor Xa (cartoon) with ligand RRR (CPK) from pdb structure 1NFW. 42
The region of interest corresponding to the GIST grid is shaded in gray. Individual voxels are not shown.
Table 2. Quantities mapped by GIST onto a user-defined
volume.

Table 1. GIST command options that define the region of
interest

Quantity

Description
Units
Translational entropy
TStrans
density
kcal/mol/Å3
Orientational entropy
TSorient
density
kcal/mol/Å3
TSsix
Total entropy density
kcal/mol/Å3
Water-water energy
Eww
density
kcal/mol/Å3
Solute-water energy
Esw
density
kcal/mol/Å3
Voxel pair interaction
Eij[a]
energy density
kcal/mol
Mean water dipole
Dipole[b]
density
Debye/Å3
Neighbor
Mean number of water
count
neighbors[c]
molecules
Average tetrahedral
Order[a]
order parameter
none
[a] Optional outputs. [b] Dipole moments are reported as
time-averaged x,y, and z,components, along with the mean
magnitude. [c] Neighbor defined by O-O distance of less
than 3.5Å.

Option

Description
Default Value
Grid centroid position[a]
gridcntr
<x> <y> <z>
0.0 0.0 0.0
Grid side length[b]
griddim
<x> <y> <z>
40 40 40
gridspacn
Voxel side length[a]
0.5
refdens
Reference density[c]
0.0334
[a] Quantities in units of angstroms (Å) [b] Quantity in units of
voxel count [c] Density in molecules per Å3; a list of
reference densities for common solvent models can be
found in the supplementary information of the GIST-cpptraj
publication38.

Using GIST-CPPTRAJ

GIST requires as input a CPPTRAJ-readable molecular dynamics trajectory file and a corresponding
topology file. It is recommended that the simulation be carried out with the atoms of the solute of interest
(e.g., a protein) restrained in the lab frame, and that the simulations be run for a minimum of 30 ns,13 with
snapshots saved every 3-5 ps for optimal use of nearest neighbor algorithms.40
A GIST study can be broken into three steps:
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Step 1. Identify and define the region of interest. The region of interest is a rectangular prism with center
(x,y,z) and dimensions (Lx,Ly,Lz) input by the user. Visualization software, such as AutoDockTools,43 can be
utilized to determine the grid center and dimensions.
Step 2. Run GIST-cpptraj. The required inputs for running GIST are the MD trajectory and topology files,
the coordinates specifying both the dimensions and center of the region of interest and the name of the
output file.
Step 3. Analyze GIST results. Visualize and manipulate output.
These steps are detailed below.
Step 1. Identify and define the region of Interest
The location, dimensions and spacing of the 3D grid are defined on the cpptraj command line:
gist gridcntr <xval> <yval> <zval> griddim <xval> <yval> <zval> gridspacn
<val>

out <filename>

Here the gridcntr x, y, and z values define the center of the grid in units of Angstroms (Å). For a proteinbinding site a good choice for the center of the grid is at one of the central atoms of a co-crystallized ligand
(Figure 9). Note, however, that a common usage is the analysis of water in a binding site in the absence
of a ligand. In such simulations the GIST analysis provides information on the structure and
thermodynamics of water that is displaced upon ligand binding. In these cases the coordinates of an
arbitrary atom in the active site may be convenient, or one may use any preferred method to identify a
central position in the binding site. In choosing the grid placement and dimension several docking GUIs
may be useful to visualize the region of interest, such as AutoDock Tools.43
The grid is divided into cubic voxels with sides of length gridspacn (Å), and hence volume
Vvox=(gridspacn)3, and the number of voxels along each dimension of the box is given by griddim.
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Smaller voxels provide finer spatial resolution in the GIST maps but require longer simulations to converge.
Based on earlier studies the default grid spacing of 0.5 Å provides a reasonable balance of speed,
resolution, and convergence of voxel-by-voxel thermodynamic quantities.
Step 2. Run GIST-cpptraj
Since GIST is incorporated into cpptraj, the topology, trajectory files, and GIST command line can all be
specified in a simple cpptraj input file. A sample input file, cpptraj.gist.in, follows, with filenames
rendered in italics.
parm topology.prmtop
trajin trajectoryfile.mdcrd 1 30000
gist gridcntr 25.0 31.0 30.0 griddim 40 40 40
gridspacn 0.50 out gist.out
go

The first line defines which topology file to use; the second defines the trajectory file and the range of
frames to be analyzed, here 30,000 frames extracted from the first 90,000 simulation frames; the third
line defines the center of the grid region to be analyzed and specifies that the region is a cube of
dimensions 40x40x40 voxel lengths; the fourth line gives the voxel length of 0.50 Å and defines the name
of the output file; and the fifth line tells cpptraj to start the analysis.
The syntax for running cpptraj with input file cpptraj.gist.in is:
cpptraj –i cpptraj.gist.in

4.1.2 GIST Algorithms
Calculation of Hydration Entropy Terms
The first order entropy calculated by GIST for a voxel k is:
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(Eq 4.1.1)

Ssw = −

R o
8 2

 g (r, )ln g (r, )ddr
k

where g(r,w ) is the pair correlation function at position r and water orientation w ,  is the number
o

density of bulk water, and R is the gas constant. For a voxel k , the spatial integral is over the volume of
the voxel as indicated by the subscript on the integral symbol. In GIST-cpptraj, S sw is evaluated using two
different methods as described below.
Method 1
The first method relies on the approximation that the orientation is independent of the position within
each voxel:13,14
(Eq 4.1.2)

g vox (r, ω)  g vox (r ) g vox (ω)

This allows the orientational and translational entropy to be evaluated separately within each voxel:
(Eq 4.1.3)

Sktrans = − R  o  g sw (r )ln g sw (r)dr
k

(Eq 4.1.4)

Skorient =

− R 
8 2

g
k

sw

(ω) ln g sw (ω)dω

The integrals are estimated using a nearest neighbors approach:44
(Eq 4.1.5)

(Eq 4.1.6)

Sktrans 


− R  Nk
  ln g NN (r) +  
N k  i =1


Skorient 


− R  Nk
  ln g NN (ω) +  
N k  i =1
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where N k is the number of water molecules found in voxel k and  is Euler's constant. The g NN
quantities are the nearest neighbor estimates for the respective g quantities:
(Eq 4.1.7)

g NN ,i (r ) =

1
trans
 VNN
,i
o

and
(Eq 4.1.8)

g NN ,i (w ) =

8p 2
orient
VNN
,i

Here, VNN ,i is the volume of a sphere whose radius is the distance from the current water molecule, i , to
its nearest neighbor.
(Eq 4.1.9)

(Eq 4.1.10)

trans
NN ,i

3
4p dtrans
=
3

orient
NN ,i

3
4p dorient
=
3

V

V

The distance in translational space is defined as the Euclidean distance between water oxygens, and the
rotational distance is a quaternion distance.39
(Eq 4.1.11)

dtrans = (x i - x j )2 +( yi - y j )2 +(zi - z j )2

(Eq 4.1.12)

dorient = 2arccos(qi • q j )

The NN distances for Methods 1 and 2, below, for waters are calculated from a superset of configurations
that includes water coordinates from all stored frames of the simulation. For rotational distances only
waters found in the same voxel are used and for translational distances waters within the same and
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neighboring voxels are used. A voxel is considered to be a neighboring voxel if it shares any of the current
voxels vertices, therefore each voxel has 26 neighbors and a voxel combined with all its neighbors form a
3x3x3 cube of voxels.

Method 2
The second method uses an NN approach to directly estimate the six-dimensional integral in Equation
4.1.1:40
(Eq 4.1.13)

Sk 


− R  Nk
  ln g NN ,i (r, ω) +  
N k  i =1


where the nearest neighbors density, g NN (r, ω) , is:
(Eq 4.1.14)

g NN ,i (r, ω) =

8 2
combined
 oVNN
,i

combined
Here, VNN
is the nearest neighbor volume for water i , which is the volume of a six dimensional
,i

sphere whose radius is the distance between water

i

and its nearest neighbor, in the combined

translational and orientational space.
(Eq 4.1.15)

(Eq 4.1.16)

combined
VNN
=
,i

6
p 3dcombined
6

2
2
dcombined = (dorient
+ dtrans
)

A water’s combined nearest neighbor distance is obtained by considering all waters found within the same
and neighboring voxels. Limiting the nearest neighbor search space to this region is computationally
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efficient and avoids the possibility that position and orientation unit magnitudes can skew the resulting
nearest neighbor distance to favor rotations or translations as opposed to their combination.45

Molecular Dynamics Simulations
GIST analysis was applied to data from molecular dynamic simulations of cucurbit[7]uril (CB7)46,47 in a box
of 1096 TIP3P water molecules, and to coagulation Factor Xa42 in a box of 27381 TIP3P water molecules.
The simulation parameters utilized for these analyses are described in detail in the introduction of chapter
5 below as well as suggested simulation parameters described in this chapters conclusion.

4.1.3 Convergence of Entropy
The convergence of the first-order hydration entropy was examined by applying both Method 1
(separated, section 4.1.2) and Method 2 (combined, section 4.1.2) to a region within 3 Å of co-crystallized
ligand RRR in the Factor Xa binding site, for MD snapshots saved at 1ps intervals. These water molecules
sampled in the protein binding site are the most restricted in the system and will converge quickly,
however for regions that are less restricted the convergence of structural and thermodynamic quantities
may require additional sampling. As shown in Figure 10 the translational entropy converges to within
0.002 kcal/mol/water of the final value after 2 ns. The orientational entropy converges to within 0.2
kcal/mol/water of the final value after 2ns; 0.04 kcal/mol/water of the final value after 10ns; and 0.01
kcal/mol/water after 100ns. Convergence of the summed entropy (Figure 10) is thus limited by the
orientational component. Interestingly, the combined method (Figure 10), which directly provides the
sum of the orientational and translational terms, converges more rapidly than the sum from the separated
method, converging to within 0.1 kcal/mol/water by 2 ns, within 0.04 kcal/mol/water by 10ns, and 0.004
kcal/mol/water after 100 ns. The agreement between both methods is excellent, as is evident from Figure
10 and the graph of the difference between the two methods as a function of simulation time (Figure 11).
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The slight difference between separated and combined nearest neighbor formulations represents the
error from smoothing within voxels in the conditionally separated formulation.

Figure 10. Convergence of per water entropy within a 3 Å volume around the heavy atoms of Factor Xa ligand RRR.
Red: translational entropy; green: orientational; blue: sum of translational and orientational; purple: combined sixdimensional total entropy (Method 2).

Figure 11. Difference in total first order per water entropy from Method 1 versus Method 2, for a 3 Å volume around
the heavy atoms of Factor Xa ligand RRR.

4.1.4 Convergence of Energy
GIST evaluates hydration energy as separate solute-water (Esw) and water-water (Eww) contributions. Here
we examine the convergence of their sum (Etot=Esw+Eww), again for the region within 3 Å of the heavy
atoms of Factor Xa ligand RRR. As shown in Figure 12 the energy is converged to within 0.1 kcal/mol/water
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of the final value within 2ns, to within 0.02 kcal/mol/water by 10ns, and 0.004 kcal/mol/water by 100ns
respectively.

Figure 12. Convergence of Etot, normalized per water molecule, for a region 3 Å around the heavy atoms of Factor
Xa ligand RRR.

4.2 SSTMAP
In this section we present solvation structure and thermodynamic mapping (SSTMap)30 a software toolset
we developed that leverages MDTraj and PARMED to process explicit water molecular dynamics
trajectories to map solvent properties (table 3) onto either a high-resolution space-filling grid in GIST or
discrete hydration sites in HSA (figure 13). This software package, developed in Python and distributed
using the popular software repository Conda, reaches a large user base and offers state of the art IST
based STM methods. In this section we first outline SSTMap’s features, then discuss the methods
incorporated in SSTMap, and finally demonstrate SSTMap functionality in combination with Scipy to
generate statistical analyses of individual hydration sites.
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Figure 13. An illustration of SSTMap Functionality. SSTMap calculates structural and thermodynamic properties of
water molecules on regions of solute surfaces that are represented as either a grid of voxels (left) or a set of highdensity hydration sites (right).

Table 3. Structural and thermodynamic quantities calculated by SSTMap.
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SSTMap Implementation Features
Installation of SSTMap
SSTMap is distributed through conda, the package manager provided with the freely available Anaconda
Python distribution, and can be installed on Linux and Mac OS operating systems, using the following
conda command:

Box 1. Installing SSTMap through command-line package manager conda.
The end-user can also download the development version of SSTMap from the Github repository and
install it as follows:

Box 2. Installing SSTMap from its github repository.

Coding Practices
SSTMap is implemented in Python 2.7, with linked C/C++ modules to speed up computationally intensive
calculations. It interfaces with the cross-platform parameter and trajectory parsing tools, namely MDTraj48
and ParmEd49 so that the solvation structure and thermodynamic analyses can be applied to trajectories
from a wide variety of MD packages including AMBER25, DESMOND50, Gromacs51, CHARMM52, OpenMM53,
and NAMD54.
SSTMap calculations utilize multidimensional NumPy arrays55 for handling numeric data, such as
coordinates and pairwise distances. The implementation of solvation analysis calculations follows an
object-oriented model. The modular structure allows for easy maintenance and future enhancements.
SSTMap is extensively documented through the use of Python docstrings, following the PEP257
conventions. Additionally, tutorials with step-by-step instructions on basic and advanced applications of
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the tool are available at sstmap.org. The source code of SSTMap is hosted on Github and is available under
an open source license.

Capabilities
Setting up Solvation Analysis Calculations
SSTMap has two main command-line programs, named run_hsa and run_gist, that generate water
structure and thermodynamic calculations in hydration sites and on a grid respectively. A generic
example of these commands is shown below (Box 3).

Box 3. Running SSTMap through command-line.
The -i and -t flags are used to specify the topology and trajectory files, respectively, corresponding to the
MD package used for simulation. The ligand PDB file, specified under -l flag, is used to define the binding
site region for either clustering for HSA or creating 3D grids for GIST. The ligand can be either a cocrystallized molecule or a set of atoms in the binding site or even a set of dummy atoms to specify a region
around which the water molecules from the entire simulation are used for analysis. There are optional
flags for specifying starting frame and a prefix to name the output files (Table 4). Some MD packages have
parameter files containing non-bonded interactions parameters. These can be specified under -p flag.
Commands specific to each MD supported packages are provided in tutorial on sstmap.org.
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Table 4. Command-line arguments for running SSTMap programs run_hsa and run_gist.

Both programs output a summary text file containing data for individual sites or voxels. This file contains
averages of the thermodynamic and structural quantities, listed in Table 4. The run_hsa program also
generates a PDB file containing the coordinates of all hydration sites identified during the calculation
(Figure 14, left) and two PDB files for each hydration site, one consisting of the full set of water molecules
found in the site during the entire length of simulation and another containing the most probable
positions and orientations of water molecules found in the site.
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Figure 14. Visualization of SSTMap output for Caspase 3 active site. Left, Hydration sites identified by HSA
calculations. Right, Three dimensional maps of water density contoured at three times bulk density, obtained by
GIST calculations.

The run_gist program calculates each quantity for each voxel inside a grid. The results are stored as Data
Explorer (DX) format files for each quantity calculated over the grid; these can be visualized in standard
molecular visualization packages such as PyMol33 and VMD34. The DX files can also be post-processed using
previously developed GIST tools38. As an example, Figure 14 (right) shows the DX map for water density
in the active site of Caspase 3, contoured at three times bulk density. The solvation analysis calculations
in SSTMap can also be applied in protein-ligand complexes. As noted in our prior implementation13,38 a
potentially useful application of GIST is to perform an end-states analysis between initial and final states,
such as a complex with unsubstituted and substituted ligand. The thermodynamic impact of water reorganization upon ligand modification can then be calculated by taking the differences in the quantities
in the initial and final states.
SSTMap can also be accessed through its application program interface (API) using Python code. The key
benefit of using the API compared to the command-line tools is the flexibility in programmatically
accessing SSTMap’s capabilities and incorporating them into larger workflows. The code in Box 4
demonstrates an example Python code that is used to initialize and run customized GIST calculations,
using the Caspase 3 example. In example 1, only energetic quantities are calculated for the grid (Box 4,
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line 8). In general, any combination of Boolean flags can be used for energy, entropy, and hydrogen
bonding calculations. In example 2, a GIST grid is initialized with a user-defined grid center, as opposed to
the default where it is automatically derived from geometric center of the ligand molecule, Box 4, line 13.

Box 4. Using the SSTMap API from Python code.

Calculation and Visualization of Water Structure
SSTMap provides not only thermodynamic quantities based on the IST formalism, but also measures of
the frustration or enhancement of water networks on solute surfaces. For example, SSTMap breaks down
the water-water energy for a voxel or a hydration site into contributions from the different solvation
shells. The contribution from the first solvation shell divided by the number of first shell neighbors
provides a measure of enhancement or frustration in the local interactions for a hydration site or a voxel
𝑤𝑤
(𝐸𝑛𝑏𝑟
in Table 4). A closely related measure of water structure is the fraction of hydrogen-bonded

neighbors (𝑓𝐻𝐵𝑤𝑤 ), the greater this fraction, the more structured the local network of water. A complete
list of structural quantities can be found in the first half of Table 4. These quantities are calculated by
default for hydration sites or GIST grids, using either the run_hsa/run_gist programs or the corresponding
functions from the API (Box 4).
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Additional functions are also available through the sstmap module for plotting water-water pair energy
distributions, characterizing local hydrogen bonding environments, and calculating water-water energy
contributions from successive solvation shells which enables investigation of long range water structure.
In the following, we demonstrate the functionality for visualizing local water structure around a hydration
site, using the distributions of water-water pair energies in the first solvation shell. The distribution is
obtained by storing individual pair interactions of every instance of a water molecule in a hydration site
with its corresponding first shell neighbors. These data are stored during HSA calculations. The histograms
of the pair interactions can be plotted as probability distributions of water-water pair-energies in the first
shell, using utility functions in the sstmap module, as demonstrated by the code listed in Box 5. For
example, a hydration site water that typically interacts favorably with one nearest-neighbor water, and
unfavorably with another, will have a bimodal pair energy distribution. In this example, distributions for
two neighboring hydration sites in Caspase 3 (top panel of Figure 15) is overlaid with the corresponding
distribution from TIP3P water model. Unlike the bulk water distribution, these distributions have peaks
indicating a significant population of both favorable and unfavorable water-water pair interaction
energies. These distributions are for two neighboring water molecules which also form strong hydrogen
bonds with residues on the protein surface, including two arginine, one histidine and one glutamine side
chains. The water molecules in these sites predominantly from unfavorable interactions with each other
while forming favorable interactions with their other water neighbors. This leads to the bimodal
distribution seen in Figure 15. Our interpretation of this is that the water molecules are geometrically
unable to simultaneously form hydrogen bonds with the protein surface and with each other and
preferably form hydrogen bonds with the protein. This causes the interaction of the hydration site water
molecules with each other to be positive on average which is reflected in the rightmost peaks of Figure
15. We address the water in these sites in further detail in our prior publication30.
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Box 5. Plotting functions to visualize distributions of water-water interactions.
In a similar manner, examples of plots for the joint probability distribution of distances and angles
between water molecules in the hydration site and their neighbors, within a distance cutoff (6.0 A by
default) is shown in Figure 15, bottom panel. These plots can be generated using Python statements
shown in Box 5 and provide a visualization of the orientation of water molecules with respect to a
hydration site. The orientation is described by the angle that corresponds to the minimum of four possible
hydrogen bond angles between the site water and its neighboring water.56 When seen in comparison with
bulk water distribution (Figure 15, bottom left), site 0 (bottom middle) shows high angle peaks (>30°) with
its water neighbors found at 4.0 to 5.5 A sub-shell. Similarly, site 4 (bottom right) shows a high probability
of finding poorly aligned water molecules in its first shell, consistent with its distribution in Figure 15 (top
right). The added advantage in these plots is that water-water interactions in distant shells can be
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analyzed. The poor water-water interactions in the long-range for a given site can be further quantified
𝑤𝑤
by obtaining the measure 𝐸𝑤𝑤 − (𝐸𝑛𝑏𝑟
𝑁𝑛𝑏𝑟 ). Taken together, the plotting functions and the quantities

describing breakdown in water-water interactions on the surface provide a useful approach to
characterize water molecules in protein cavities, as noted previously30.

Figure 15. Analysis of local water structure SSTMap. (Top) Probability distributions of pair energies of water
molecules in hydration sites with their first shell neighbors (shown for Caspase 3 sites 0 and 4, overlaid with the
same distribution for bulk water). Bottom row (from left to right): Two dimensional distributions of the angle and
distance between hydration site water molecules and their neighbors for bulk water, Caspase site 0, and 4.

Analysis of Hydration Sites/GIST Grids
The sstmap module can be used with existing molecular simulation and data science packages for more
advanced applications, such as automating solvation analysis and performing statistical analyses of
hydration site datasets or GIST grids. The automation of solvation analysis for multiple trajectories or a
large number of systems can be processed simply by looping over all the systems and using Python
statements similar to the ones shown in Box 4 for each iteration. For simulation programs that offer a
Python API (e.g., OpenMM53), every step of the system preparation, simulation and analysis can be
automated, thereby facilitating reproducibility of results.
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Python’s popular data analysis and visualization packages (e.g., pandas, scipy.stats, scikit-learn,
matplotlib, jupyter notebook, see reference57) can be used to enhance the analysis of datasets of hydration
sites or GIST grids obtained from SSTMap calculations. For example, determining characteristics of
hydration sites that are involved in ligand binding can be valuable in understanding water displacement.

Box 6. Analysis of hydration site datasets.
We demonstrate such usage of sstmap by an example code listed in Box 6. The goal in this analysis is to
determine how interaction with charged groups on protein surfaces affects local water structure.
Typically, high energy hydration sites are considered to contribute favorably to ligand binding upon
displacement14,58. However, it is difficult to evaluate hydration sites where water interacts strongly with
the protein and is, generally, enthalpically favorable relative to bulk. The Python script in Box 6 reads in a
dataset of 218 hydration sites from six different proteins that was generated in a prior publication30 and
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is publicly available. The script loads the dataset as a pandas data-frame, which facilitates extracting
Individual columns for different subsets of hydration sites (Box 6, lines 8-14), which in this case is a set of
hydration site categorized as charged sites (See reference 18 for definition).
A scatter plot (Figure 16) and a linear regression model (Box 6, lines 15-17) is generated to analyze the
relationship between solute-water interaction and perturbation in local water structure. As the
interactions with the surface strengthen, local water structure is increasingly disrupted. In particular, sites
above the dashed line have significantly less favorable 𝐸𝑛𝑏𝑟 than bulk water, and form strong energetic
interactions with the surface at the expense of poor interactions with first solvation shell water neighbors.
It is expected such water molecules gain favorable first shell interactions in bulk, which may be a relevant
contribution in displacement.

Figure 16. The effect of solute-water interaction on local water structure. The scatter plot is generated from a set
of hydration sites where water molecules form hydrogen bonds with the charged side chains in active sites.
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We conjecture that similar analyses, combined with prospective studies of targeted water displacement,
will generate new insights about the properties of water molecules in active-sites. SSTMap provides
programmatic access to a range of thermodynamic and structural properties of binding site water, using
both the hydration site and grid representations, and it processes trajectory data from multiple widely
used simulation packages. It is therefore well-suited to facilitate such studies.

4.3 Post-processing results with GISTPP
To aid in GIST analysis we have developed a suite of post-processing tools, GISTPP, which facilitates the
manipulation of GIST output files. The GISTPP package provides a comprehensive set of operations that
allow end-users to easily manipulate the dx files generated by GIST. Each command specifies an
operation, one or two input dx files, an output file, and any options related to the operation:
gistpp –i infile -i2 infile2

–op operation –opt options

–o

outfile
A list of the key operations and brief explanations can be found in Table 5. A user manual can be found at
ambermd.org.59

Table 5. Selected GISTPP operations with descriptions
Operation

Description
Multiplies two dx maps together
Adds two dx maps together
Subtracts dx map 2 from dx map 1
Divides dx map 1 by dx map 2
Create a binary dx[a] map of voxels
filter1
that are above or below a threshold
Integrates all voxel quantities in a
sum
given dx map, printing the sum
Create a binary map around a pdb
structure by flagging all voxels found
within a user defined distance of all
defbp
heavy atoms.
Creates a dx map of the real solvent
accessible surface,60,61 which
comprises voxels where the water
density is greater than 0.1 of bulk
density (g(O) >0.1) and at least one
neighbor voxel has water density less
SAS
than 0.1 of bulk (g(O) <0.1)
[a] A binary map contains a 1 in each voxel that meets a
criterion and a 0 in each voxel that does not.
mult
add
sub
div

For example, two dx files can be easily summed together from the command line:
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gistpp –i gist-Eww-dens.dx

–i2 gist-Esw-dens.dx –op add –o

Etot.dx
Here, the solute-water energy map and the water-water energy map are summed to obtain a dx map,
Etot.dx, of the total water-system energy.

Solvent Accessible Surface Mask
GISTPP offers a solvent accessible surface mask operation that produces a binary data explorer file from
a provided oxygen density data explorer map that labels the voxels that define the solvent accessible
surface. The solvent accessible surface is the surface that describes the most proximal location's water
can occupy relative to a solute, which represents the effect surface that a drug molecule may occupy when
binding the active site. Here we provide an example command for masking out the solvent accessible
surface of a biological solute of interest:
gistpp –i gist-gO.dx –op SASA –o SAS.dx

Ligand Mask
More complex manipulations can be achieved with sequential GISTPP operations. For example, in a
previous study, we found that the displacement of high energy and high density water from the Factor Xa
binding site was highly correlated to protein-ligand binding affinity.14 To map out such regions, we would
first add the water-water energies and the solute-water energies to obtain a total energy map (as shown
above). One may then create binary maps, which define voxels with high density and high energy,
respectively:
gistpp –i gist-gO.dx –op filter1 -opt gt1 -opt cutoff1 2
Highdens.dx
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-o

gistpp -i Etot.dx

-op filter1 –opt gt1 –opt cutoff1 -9.53 -o

HighEnergy.dx
Multiplying the binary maps of high density and high energy creates a binary scoring map, which marks
only those voxels at both high density and high energy:
gistpp -i Highdens.dx

-i2 HighEnergy.dx

-op mult -o

ScoringRegions.dx
The scoring regions displaced by a given ligand can then be mapped out by creating a mask of water that
is displaced by a given ligand, defined by a PDB file, here RRR.pdb from a congeneric pair study:58
gistpp -i ScoringRegions.dx

-i2 RRR.pdb

-op defbp -o

DisplacedRRR.dx
gistpp –i DisplacedRRR.dx –i2 ScoringRegions.dx –op mult –o
ScoringRegionsRRR.dx
As in our previous study the solvent displacement score for each ligand can then be calculated by finding
the number of scoring voxels displaced (Figure 17):
gistpp -i ScoringRegionsRRR.dx

-op sum

In our previous study,14 we found that the differences in these scores for congeneric pairs of ligands were
highly correlated (R2=0.92) with relatively binding affinities from experiment.
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Figure 17. Scoring regions of two ligands from a congeneric pair study of Factor Xa, ligand RRR (left, purple) and
4QC (right, green).58

Integration over defined subvolume
GISTPP offers a summation operation which allows end-users to integrate solvent thermodynamic and
structural properties over a defined volume. The default involves integrating the provided data explorer
file over the full GIST region, however by combining ligand masks and filtering by a threshold this
summation operation can be used to integrate thermodynamic and structural quantities over userspecified volumes in a drug design context.
These operations available in GISTPP enable end-users to investigate the structural and thermodynamic
properties of water molecules on biological surfaces and glean pertinent data for application in a
computer-aided drug design context. An example application of GISTPP integration over sub-volumes is
discussed here in an end-states analysis context.
In previous studies we correlated Factor Xa binding affinities with water properties from GIST using a
displaced solvent functional.14,58 This analysis relied upon the investigation of the displacement of water
from the protein binding site alone and did not include contributions from the solvent reorganization
upon binding or from the desolvation of the ligand.
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Here we outline how GIST-cpptraj can be used to estimate Gsolv of a ligand-binding event that includes
both the solvent reorganization around the complex and the desolvation of the ligand. In order to do this,
three independent MD simulations would be run and analyzed by GIST: the solvated protein-ligand
complex, the protein and the ligand. The first step of the analysis would be to identify a region in which
the water is energetically and entropically perturbed from bulk values around the solute. This is illustrated
in figure 18.

Figure 18. End states volumes defined around ligand RRR (a, blue), Factor Xa (b, yellow), and the complex formed
by these two molecules (c, green). The free energy of solvation defined by these volumes can be used to estimate
the free energy of solvation during the binding of ligand RRR.

The next step would be to calculate the perturbation of energy and entropy of the water from bulk in
each of these three regions.
(Eq 4.3.1)

Esolv = ( Ei ) − NEbulk
i =1

(Eq 4.3.2)

S solv = ( Si ) − NSbulk
i =1
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Where 𝐸𝑖 and 𝑆𝑖 are, respectively, the energy and entropy of water found within voxels 𝑖 the region of
interest, 𝑁 is the average number of waters in the perturbed volume, 𝐸𝑏𝑢𝑙𝑘 and 𝑆𝑏𝑢𝑙𝑘 are the energy and
entropy of a single water molecule in the neat solution. The free energy of perturbation would then be:
(Eq 4.3.3)

DGsolv = DEsolv - TDSsolv

bind
The change in solvation free energy for the binding process, Gsolv
, would be:

(Eq 4.3.4)

bind
complex
protein
ligand
Gsolv
= Gsolv
− ( Gsolv
+ Gsolv
)

Example GISTPP commands that accomplish this approach for Factor Xa and ligand RRR were described
in our previous publication38.

Visualization of GIST data using GISTPP
GIST-cpptraj and SSTMap outputs gridded maps of solvent thermodynamic and structural quantities in dx
file format, which can be visualized in most model viewing software, such as VMD and PyMol.33,34
Quantities not printed in dx files by default can be found in the text output and can be converted into dx
format, if desired, by GISTPP. When visualized, these maps highlight key features of surface solvation such
as high-density regions, or regions where the solvent interacts favorably with the surface or has
unfavorable entropy, as illustrated for CB7 in Figure 19. Though in this example we demonstrate the utility
of GIST on a host-guest system an in depth application of GIST on a protein-ligand system has been
demonstrated previously and is also shown in the AmberTools GIST tutorial.14,59,62

48

Figure 19. Sample visualizations of GIST output for host molecule CB7. a) Solvation shells around CB7 produced by
visualizing gist-gO.dx with cutoff 0.98. b) Favorable solute-water interactions found near the oxygens of CB7,
produced by visualizing gist-Esw-dens.dx with cutoff -0.24 (kcal/Å3). c) Unfavorable combined entropy found
between the oxygens of CB7, visualized from gist-dTSsix-dens.dx with cutoff -0.18 (kcal/Å3).

4.4 BiggerGist
GIST analysis on large scale systems of interest, such as the full surface of a globular protein, presents a
challenge due to runtime and memory limitations. To circumvent these limitations we developed a
methodology, called BiggerGist, that takes a large GIST region of interest and separates it into an even
number of smaller GIST regions that can be independently analyzed (figure 20). After the serial GIST
calculations have been completed the BiggerGist protocol then recombines the smaller subsections into
their original large region of interest, which allows end-users to evaluate solvation thermodynamic and
structural properties on arbitrarily large regions of interest.
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Figure 20. Schematic of BiggerGist protocol to divide a large GIST region of interest (left), into an even number of
smaller GIST regions that overlap by one layer (middle and right), that are then recombined into the larger region
upon serial calculation.

4.5 Software Development Conclusion
In this chapter we discussed the contributions that we have made over the course of the works described
in this thesis to solvation thermodynamic mapping methods that incorporate inhomogeneous fluid
solvation theory. The incorporation of GIST into AMBER CPPTRAJ analysis suite affords a powerful opensource tool for computing and mapping the properties of water at molecular surfaces in high resolution.
The release of GIST-CPPTRAJ is supplemented by GIST post processing, which facilitates a wide variety of
analyses and visualizations, as well as a web-tutorial and user manual to ensure end-users can learn to
use our open-source code. Alongside the software developed for this package we published a tutorial
onto the AmberMD website (http://ambermd.org/tutorials/advanced/tutorial25/) that enables novice
and expert end-users alike to learn GIST and apply it in a computer-aided drug-design context. The AMBER
community was further supported by our assisting end-users on the AMBER mailing list. A number63–69 of
research programs have successfully applied GIST-CPPTRAJ in publications without any support from us,
providing evidence that GIST-CPPTRAJ represents a ‘canned’ software package that is ready to be
deployed with minimal instruction.
Similarly, we discussed the development of SSTMap, a tool that combines the discrete site based mapping
of hydration site analysis and grid inhomogeneous solvation theory, into a python codebase that leverages
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MDTraj and PARMED software packages to process most popular molecular dynamics file formats. We
included the improved nearest neighbor approximation for entropies in both the site based and gridbased implementations of STM in SSTMap, as well as a number quantities that were not included in
previous implementations of IST based STM methods. The flexibility of python enables end-users to
incorporate SSTMap into automated analyses scripts that can produce data that is reproducible.
Alongside these STM methods we developed software packages that support GIST enabling flexible
applications of this robust STM package. Notably, these support packages include GIST post processing
(GISTPP) and BiggerGist. BiggerGist enables end-users to perform GIST on arbitrarily large regions of
interest such that analyzing full protein surfaces no longer presents a technical challenge whereas GISTPP
provides several operations designed to enable end-users to perform in-depth analyses of active site
water properties in a drug-design context. The culmination of these efforts have resulted in the
application of GIST in published research by academics that have made no contact with our group for
additional assistance implying that the provided STM tools are not only robust in their formulations, but
also end-user friendly products that can be applied by most computational research groups. These works
have substantially improved the field of solvation thermodynamic mapping in computer-aided drugdesign.

Selection of Simulation Parameters
Here we discuss suggested simulation parameters that are relevant for running HSA/GIST analysis in both
SSTMap and GIST-CPPTRAJ.
Simulation length: The length of production simulation depends on the desired precision. Unless there
are buried sites or cavities that are difficult for bulk water to access, a 2-10 ns simulation, with frames
saved every picosecond (2-10K frames), is generally sufficient for qualitative maps that clearly and reliably
show the spatial distribution of water density, energy, and entropy. For quantitative end-states
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calculations, convergence of system and/or regional quantities with multiple water molecules to within a
desired precision requires longer simulations. Convergence of GIST quantities were reported in our
previous publication and is discussed above in section 4.1.3 and 4.1.438, with entropy per water molecule
converging to within 0.1 kcal/mol per water by 2 ns, 0.04 kcal/mol per water by 10 ns, and 0.004 kcal/mol
per water by 100 ns and energy being 0.1, 0.2 and 0.04 kcal/mol per water for the respective time scales.
It should be noted that these quantities are reported for water molecules that occupy the protein active
site and will not reflect the convergence properties of water molecules in a less restricted environment.
Grid spacing: The convergence of thermodynamic quantities integrated over the entire grid does not
depend on the grid spacing. However, the convergence of quantities in each voxel depends on the grid
spacing as it is directly affected by the number of water molecules found in the voxel over the course of a
simulation.
Constant pressure or constant volume simulation: Most applications of GIST/HSA focus on the solvation in
a given sub-region (e.g. the active site of the protein which does not include the entire simulation box). In
this case either NVT or NPT is appropriate. However, for thermodynamic end states analyses, which
require a treatment of all the molecules in the system, simulations should be run in NVT, in order to avoid
mismatches between the grid and the simulation box which would occur at constant pressure, due to
fluctuations in the box dimensions. Therefore, after allowing the system to equilibrate at NPT to establish
a volume appropriate to 300K and 1 atmosphere, the production run is often done at constant volume. It
is also better to run NVT simulations using the average box volume from the NPT simulation instead of
choosing the final box volume. The final volume may correspond to a large volume fluctuation from the
average in the NPT ensemble and can lead to a significantly different mean energy of the system.70
Solute atom restraints: IST equations are exact when all atoms for the protein are held fixed; see
comments on limitations below. However, treating the protein as entirely rigid eliminates protein
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fluctuations that can lead to informative adjustments in water structure, such as ones that allow
optimization of H-bonds between the protein and water molecules. In order to explore various
possibilities, we may run simulations with all protein-heavy atoms restrained; only backbone atoms
restrained; or with only restraints designed to prevent overall translation and rotation.

Limitations
The solvation mapping methods discussed here include some limitations and approximations, of which
users should be aware. Perhaps most straightforward is the fact that the molecular simulations needed
to generate the maps rely on potential functions, or force fields, that are not perfectly accurate. In
addition, simulations need to be long enough to achieve adequate convergence. As detailed below,
obtaining converging solvation thermodynamic quantities is usually straightforward for solvent-exposed
sites, but standard simulation methods may not readily equilibrate the water population in a buried site
or protein cavity. Several additional points are discussed in the following paragraphs.
First, IST provides an N-body expansion for the entropy, where N is the number of water molecules in the
system, and applications of IST typically truncate this expansion after the first order term. This truncation
means that entropic contributions due to solute-induced changes in second- and higher-order waterwater correlations are omitted. Computing these correlation terms requires longer simulations and more
complex analysis methods, but studies of pure water suggest they are quantitatively important,22,71 and
progress has been made toward quantifying how they are perturbed by solutes. In one approach, the
computational challenge is limited by computing orientational correlations only in the first hydration
shell63, where they are likely to be most perturbed relative to bulk. In addition, we have recently reported
progress in calculating entropic contributions from translational water-water correlations72. The
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contribution of water-water correlations to the entropy has also been estimated as proportional to the
first order entropy40,73, but additional work is needed to assess the quality of this approximation.
Second, with a few exceptions74,75 applications of IST have used an initial states approximation. This
involves analyzing the water in an initial state with an unoccupied binding site or a binding site containing
an unmodified lead compound, without further analyzing water properties in a final state, following
binding of a ligand or modification of the lead compound, respectively. Fully accounting for the
thermodynamic consequences of water reorganization would require would require looking at both the
initial and final states. Such calculations can be performed with SSTMap and GIST-CPPTRAJ, though at the
cost of an additional simulation for each final state of interest. It is also worth noting that a number of
studies indicate that the initial states approximation can have predictive value14,58,76,77.
Third, IST relies on Percus’s source particle method20,78 which treats the solute molecule, typically a
protein, as a rigid object. This means that protein motions associated with water rearrangements are not
accounted for. If one is using the IST results in the context of docking calculations, which often treat the
protein as rigid, this may not be a major concern. However, if one wishes to account for protein flexibility,
a natural approach is to simulate the protein without restraints, cluster the resulting conformations, and
then run IST calculations for representative rigid snapshots of each highly populated cluster.
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Chapter 5 – Applications of STM
In this chapter we discuss the application of IST based STM methods in a computer aided drug design
context through two applications. The first application utilizes hydration site analysis to inform the
rational lead modification of (-)-stepholidine an antagonist of human dopamine receptor 3, which led to
synthesis of a series of analogs that were assayed in vitro through the Psycho Active Drug Screening
Program. The second application utilizes hydration site analysis to sample active site water structural and
thermodynamic quantities to build a Water Based Pharmacophore that can be used to screen compound
databases. These two applications relied extensively on in silico experimentation and validation as well as
in vitro experiments in the first discussed application. These works were in close collaboration with Dr.
Wayne Harding at Hunter College, Dr. Ian Alberts at La Guardia Community College, and Dr. Art Cho at
Korea University. This chapter begins by briefly detailing the in silico experimental parameters applied in
these applications, then discusses the application of STM in a rational lead modification context in section
5.1, and finally discusses the construction of a Water Based Pharmacophore method in section 5.2.

Molecular Dynamics Methods applied in these applications
The two projects described in this chapter applied hydration site analysis in a computer-aided drug design
context. In this section, we quickly outline the in-silico procedures used to generate water configurations
via molecular dynamics simulations as well as the details regarding the STM characterization of active site
waters. The protein targets in this thesis were prepared for molecular dynamics simulations with use of
the Maestro Protein Preparation Wizard, with human intervention regarding the definition of protonation
states and rotation of amino acid residues, in particular, residue types asparagine, glutamine, and
histidine. The preparation wizard was otherwise utilized to protonate the provided crystal structures and
cap terminal residues. Simulation systems were generated from apo protein structures exported from
Maestro in Amber using leap to define the simulation box, encase the protein in water with a 10 Å buffer
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length, and neutralize the system charge with sodium or chloride counter ions where appropriate.
Molecular dynamics simulations were performed with these prepared systems using the AMBER24
molecular dynamics package with the following minimization and equilibration protocol. The simulations
were performed with harmonic restraints on protein heavy atoms and therefore all minimization and
equilibration were performed on all atoms that had unrestricted motion. First minimization was
performed with 10000 steps steepest descent on the unrestrained atoms in the system, followed by a 200
ps simulation under NVT conditions where the system temperature was increased stepwise from
crystallographic temperatures to biological temperature 300 K. The systems were then equilibrated in
NPT conditions for 2 ns to allow the molecular density to reach experimental conditions. Finally, molecular
dynamics simulations were performed for 10 ns in NVT conditions to sample water configurations at the
protein active site surface for later STM analysis.

Hydration Site Analysis methods details
Hydration site analysis was utilized to characterize active site water properties in these works. To define
hydration sites clustering on water oxygen positions was performed within 5 Å of the co-crystal ligand
pose in the simulation box. This clustering defined hydration sites at water oxygen positions that
contained the maximum number of other water molecules within a 1 Å radius sphere. Hydration site
structure and thermodynamic quantities were reported as the average per water values for all water
molecules found within this 1 Å sphere for each cluster. The thermodynamic quantities were determined
directly from forcefield parameters in the case of interaction energies and with the nearest neighbor
entropy methodology outlined in chapter 2 for entropic contributions.
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5.1 Rational Lead Modification of (-)-Stepholidine
Human Dopamine Receptor (D3R) is a GPCR or seven transmembrane helix protein. It is a member of the
Dopamine 2-like family and has been noted to have a comparable binding site to both Human Dopamine
Receptor 2 (D2R) and Human Dopamine Receptor 4 (D4R). At the time of this study, there was one crystal
structure of D3R and no publicly available structures for D2R or D4R. At the start of our study, we
investigated the crystal structure of D3R (PDB: 3pbl) using an explicit solvent MD trajectory analyzed with
both HSA and GIST. An important quality of the dopamine receptors is that they each evolved to transmit
a signal when the neurotransmitter dopamine binds in their active site. That behavior is conserved across
all five human dopamine receptors. In these works where the desired pharmacological effect requires the
antagonism of D3R with specificity over D2R, the evolutionarily conserved binding sites have considerable
homology (figure 21). This presents a significant problem in developing a small molecule compound that
is specific for one target over the other. Fortunately, the conserved binding site of both proteins known
as the orthosteric binding site where dopamine binds has a secondary binding site adjacent to the
extracellular side. This secondary binding pocket does not have the evolutionary constraint of binding
dopamine and therefore is more likely to contain differences between the two receptors making it a
tractable target for designing rational lead modifications that are specific for D3R over D2R (see ECL
overlaps in figure 21).
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Figure 21. Overlap of Human D3 Receptor (Blue) and Human D2 Receptor (Red). The side view (left) shows that the
two crystal structures (PDB:3PBL D3R15, PDB:6CM4 D2R79) overlap well with all seven transmembrane helices
aligning well. In the middle, we see the view from the extracellular side of the proteins, with its three extracellular
loops labeled. Here, we can see that there are large differences in the loop placements between each structure
indicating a potentially large difference in secondary binding site. In the rightmost figure, we show high energy
hydration sites (spheres) for both D2R (red) and D3R (blue) viewing the active site through a transparent ECL3. There
are notable differences in high energy hydration sites in the secondary binding site near ECL2 and ECL1.

The first step to modeling rational lead modifications onto (-)-stepholidine is to generate a bound
conformation. The public domain contains only one structure for D3R (PDB:3PBL15), which is bound to a
different antagonist ligand Eticlopride. To approximate an initial (-)-stepholidine bound configuration we
performed docking experiments with both GlideSP and AutoDock43,80 wherein we generated a number of
complex configurations. Based on our knowledge of the D3R active site and its conserved interactions at
ASP110 we selected a docked pose that placed the protonated nitrogen in (-)-stepholidine proximal to
ASP110, forming a salt bridge interaction (figure 22).
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Figure 22. Two representations of our approximated (-)-stepholidine initial bound configuration to D3R (PDB:
3PBL15)., left, a three-dimensional representation and right, a two-dimensional interaction map for (-)-stepholidine
docked to D3R The salt bridge formed by the protonated nitrogen and ASP110 is a key contact that anchors SPD in
place.

To develop (-)-stepholidine modifications that target the secondary binding site we first performed STM
with HSA and GIST on the full active site, which contained both the orthosteric and secondary binding
sites. We focused on the thermodynamics of hydration sites that were proximal to, but not overlapping
with our initial configuration of (-)-stepholidine bound in the orthosteric binding site. There were two
notable hydration sites that demonstrated a displaceable thermodynamic profile, one hydration site (site
16) in the orthosteric binding site in a hydrophobic cup subpocket. The targeting of this hydrophobic subpocket with modifications to (-)-stepholidine was deemed geometrically challenging based on our initial
bound configuration. The second hydration site (site 20) that demonstrated a displaceable profile was
found in the secondary binding site on the surface of ECL2 (figure 3). Analysis of the most probable
configuration of water molecules in hydration site 20 suggested that ligand analogs that displaced water
in this site should replace the hydrogen bond formed between these water molecules and the Threonine
on the protein surface (figure 3). We approximated the construction of potential lead modifications that
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could target this displaceable water in silico and developed a series of compounds that modify (-)stepholidine at the C10 position, discussed further in sections 5.1.1 and 5.1.2.

5.1.1 Medicinal Chemistry (Performed by Collaborators at Hunter College)
Our collaborators at Hunter College, the Harding Lab (Dr. Wayne Harding, Satishkumar Gadhiya, and
Pierpaolo Cordone) performed the challenging synthesis of (-)-Stepholidine analogs to create the series
of compounds discussed in the previous section from an in silico perspective. The details of this synthesis
are outside the scope of this thesis and can be found in the following publication26. Their amazing work
culminated with in vitro assays of the (-)-Stepholidine analog series via the Psycho Active Drug Screening
Program (PDSP), assay experiments conducted in triplicate. The data for these assays have been
summarized in table 6, which show that the series of analogs produced by this work did not display a clear
improvement in dissociation constants (-)-Stepholidine, indeed that large modifications result in worse
results. It has been shown that ligand efficacy scales with the residence time (inverse off rate) rather than
dissociation constants, therefore the assessment of analog off rates is of great interest when assessing a
series of compounds. Unfortunately, assay results provided by the PDSP do not include the decomposition
of dissociation constants to on rate and off rates, which prevents forming conclusions regarding ligand
binding efficacy between these analogs. Fortunately, these assay data do proport that particular
modifications may lead to a bonus in specificity for D3 over D2 (compounds 10-14,16), which is a promising
result that was explored in future works that are outside the scope of this thesis, but have been published
since the works described in this section.27,81
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Table 6. Affinity data (Ki in nM) for C10 analogs at dopamine and sigma (σ) receptors

Compound
(±)-1
10
11
12
13
14
15
16
17

R
H
Me
Et
n-Pr
n-Bu
n-Pent
n-Hex
Hydroxypropyl
Cyclopropylmethyl

D1b
5.6g
15
12.4
7.8
11
19
40
6.7
12

D2c
115.5g
102
159
99
121
283
NAh
211
54

D3d
101g
37
44
53
65
101
220
110
54

D2/D3
1.1
2.8
3.6
1.9
1.9
2.8
NDi
1.9
1

a

Experiments carried out in triplicate - SEM values are within 13% of reported K i; b [3H]SCH2390 used as radioligand; c [3H]Nmethylspiperone used as radioligand; d [3H]N-methylspiperone used as radioligand; g experiments carried out in duplicate; hNAnot active (<50% inhibition in primary assay); iND - not determined

Alongside these assay results, our collaborators in the Harding Lab at Hunter college synthesized a set of
flexible (-)-stepholidine analogs where the original lead scaffold was disrupted through the derigidification of its six-membered rings through the removal of covalent bonds. These compounds did not
significantly improve binding affinity for the target of interest D3R, however, these compounds did display
an interesting trend in specificity over D2R, which was further investigated in future works outside the
scope of this thesis (table 7).27,81

61

Table 7. Ki data for flexible analogs

Compound
19
20
21

D1b
833
3111
>10000

D2c
1095
>10,000
>10000

D3d
1367
2680
1811

a

Experiments carried out in triplicate - SEM values are within 13% of reported K i; b [3H]SCH2390 used as radioligand; c [3H]Nmethylspiperone used as radioligand; d [3H]N-methylspiperone used as radioligand

5.1.2 Computational validation of analogs (docking and MD)
To accompany the experimental validation performed in the previous section by our collaborators at
Hunter college we also performed a set of computational validation on the series of (-)-stepholidine
analogs in collaboration with Dr. Ian Alberts at La Guardia Community College. These computational
validations included the docking of (-)-stepholidine analogs to D3R crystal structure (PDB 3PBL15) using
GlideSP80 and assessing the stability of the three flexible compound poses in molecular dynamics
trajectories using AMBER MD24.
The predicted binding affinities with GlideSP suggested that the (-)-stepholidine analogs in are not likely
to provide significant improvements to binding affinity over the lead compound, which matches the PDSP
assay data quite well (table 8).
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Table 8. Predicted binding affinity from GlideScore and ligand strain energy for C10 and flexible analogs at the D3
receptor prepared from the crystal structure with PDB code 3PBL

Compound

R

(±)-1
10
11
12
13
14
15
16
17
19
20
21

H
Me
Et
n-Pr
n-Bu
n-Pent
n-Hex
Hydroxypropyl
Cyclopropylmethyl

SP
Glidescore
-7.9
-7.5
-7.4
-7.5
-7.4
-7.5
-7.3
-8.1
-7.3
-6.2
-6.3
-6.4

Ki (nM)
101
37
44
53
65
101
220
110
54
1367
2680
1811

In particular analogs, 10-15 which stepwise add hydrophobic carbons to elongate the hydrophobic tail
onto site C10 perform worse as the hydrophobic tail increases in size. Compound 16, which extends an
alcohol functional group at a length that can replace the water molecule in site 20 discussed above in
section 5.1, was predicted by GlideSP to perform slightly better than our lead compound largely due to its
top pose including a hydrogen bond formed by this alcohol functional group to the protein surface (figure
23).

Figure 23. The docked pose of the hydroxypropyl analog, compound 16.
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Interestingly, the flexible compounds 20 and 21 adopted a unique binding mode while maintaining the
hydrogen bond between Asp110 and the protonated nitrogen on (-)-stepholidine (figure 24). These
flexible compounds were predicted by docking to perform worse than our lead compound, which matched
the experimental results from PDSP.

Figure 24. Docked poses of the flexible analogs, compounds 20 and 21.
To further assess the stability of our flexible compound docked poses (19-21) we performed analysis with
molecular dynamics for 100 ns sampling time to confirm that our predicted docked pose remained in the
D3R pocket. We assessed the stability of these compounds by measuring ligand RMSD compared to our
docked poses (figure 25) and distance from ASP110 (figure 26) as metrics that define that these ligand
configurations remained within the binding pocket for the full 100 ns.
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Figure 25. RMSD of flexible compounds 19 (left), 20 (middle) and 21 (right) between all-atom coordinates at each
frame, compared to the coordinates of the docked pose (starting configuration). All three compounds display limited
motion within the binding site, fluctuating about their original docked pose.

Figure 26. The distance between flexible compounds 19 (left), 20 (middle), and 21 (right) center of mass and the
key aspartate Asp110 over the course of a 100 ns simulation. All three ligands maintain this contact throughout the
sampled time.

5.1.3 Future in silico modeling experiment (-)-stepholidine bound to D3R
The incorporation of solvation thermodynamic and structural mapping into drug design projects has
shown promise over the last decade as we outlined in section 5.1 in our discussion of the validations
performed in the literature. In these works, we applied STM to the rational lead modification of (-)stepholidine for both affinity and specificity towards its target human dopamine receptor 3 over its offtarget human dopamine receptor 2. To do so we applied hydration site analysis to the secondary binding
pocket of D3R. We then produced two series of (-)-stepholidine analogs that targeted the secondary
binding pocket of D3R and observed their results. We found some promise in developing novel analogs
that improve the desired pharmacological profile of our lead compound (-)-stepholidine. These results
show that targeting the D3R active site for both affinity and specificity over D2R is a difficult task. Our
work demonstrates that the modification of (-)-stepholidine, a lead compound that has a favorable
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pharmacological profile, can be modified at both C9 and C10 substituent sites to provide a slight gain in
specificity. Interestingly, the analogs that were produced with flexible scaffolds have clear specificity
towards D3R over D2R, however, it is unclear by what mechanism these flexible compounds provide said
specificity.
Given these successes there remain several molecular modeling steps that can be performed to improve
our rational lead modification strategies using STM. One such improvement is the inclusion of the recently
solved structures of D2R and D4R, the other members of the D2-like family of dopamine receptors. A
surface-level comparison of D3R and D2R crystal structures and their active site waters can be seen in
figure 21, however, an in-depth analysis of the secondary binding sites of these three structures is
required to accurately target lead molecule modifications that will result in specificity. Indeed, the
structures deposited in the RCSB represent rigid structures bound to specific small molecule compounds,
none of which are similar to (-)-stepholidine in structure. Given the high flexibility of GPCR’s the active site
surface that can be modeled from these structures likely does not reflect the active site configuration that
will be present when either no ligand is present or (-)-stepholidine is bound. This presents a challenge for
modeling rational lead modifications or active site water structure and thermodynamics in that when
using these receptor configurations we are approximating that the rigid structure bound to an antagonist
will be similar to the (-)-stepholidine bound structure. A computational approach to overcoming this
difficulty relies on long scale MD simulations of D2R, D3R, and D4R where all three structures are
embedded in a lipid bilayer, encased in water molecules, and simulated both apo and bound to (-)stepholidine. These long scale simulations will sample the configurations these proteins will adopt in the
absence and presence of (-)-stepholidine to the accuracy of state of the art force field parameters.
Considerable calculation time and structural analyses will be required to glean potential structural
patterns in each active site that can be used to target modifications of (-)-stepholidine. Ultimately, the
results of said MD sampling will approximate the three complexes until experimental results validate the
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models, however, these data may provide unique ideation for targeting the secondary binding site of D3R
which is composed partially of flexible extra-cellular loops. On a similar vein, the inclusion of free energy
calculations in an implicit solvent with explicit solvent corrections with BEDAM provides an additional
resource for determining differences in (-)-stepholidine or its designed analogs for each of these
structures. With the newly available PDB structures, there remains a plethora of computer modeling that
can be performed and perhaps identify targetable differences in the structures, most of which will be
applied in future work.

5.2 Water Based Pharmacophore virtual screening
Active site water structure and thermodynamics can be useful in predicting small molecule drug binding
behaviors. This is exemplified by the example of the five-membered ring of water in streptavidin where
the water molecules closely mimic the hydrogen bonding character of the co-crystal compound biotin.
This feature of active site water makes it applicable in a virtual screening context where water can be used
to map out functional features of a potential drug-like molecule. The search through virtual compound
databases using a set of functional features can be performed using a pharmacophore screen.
Pharmacophores are abstract three-dimensional representations of key interactions between ligand
molecules and the protein surface. This method is typically applied by sampling several known ligand
bound configurations overlaid to determine features that they have in common, such as hydrophobic
groups, hydrogen bond donor, hydrogen bond acceptor, charged, and aromatic features. A threedimensional map of these common features can then be used to scan a virtual compound database and
matches or partial matches to these pharmacophore maps can then be more thoroughly considered as
potential lead molecules in a drug design context.
Water can be incorporated into the pharmacophore method in several different ways. In this application,
we will be exploring the use of solvation thermodynamic mapping with hydration site analysis as the basis
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of defining pharmacophore features. We call this technique Water Based Pharmacophore. In this method,
the position of pharmacophore features are defined at hydration site locations and the feature types are
determined directly from the structural and thermodynamic information mapped to the hydration site.
As an example, a hydration site with high energy may be indicative of a hydrophobic environment and
could be considered as a rule to define a hydrophobic pharmacophore feature. In this chapter, we explore
a proof of concept study wherein we investigate applying a pharmacophore feature selection criteria
scheme to hydration site analyses of seven pharmaceutically relevant DUD-E systems. The results of this
work show that using water structure and thermodynamics to construct a pharmacophore feature map
can successfully scan through compound databases and result in enrichment. Further studies will be
necessary to develop the Water Based Pharmacophore into a method that can be applied in a prospective
drug design setting, which will be discussed in section 5.2.3.
The majority of potent drug molecules bind to their target protein's active site by forming optimized
complementary interactions with said surface. In the absence of that drug molecule, the protein active
site is solvated by water molecules, which form analogous complementary interactions with the active
site surface, forming hydrogen bonds and hydrophobic interactions where appropriate. Water, therefore,
mimics the key interactions that a high-affinity small molecule drug compound must have to bind that
target protein. This concept can be visualized directly through the Streptavadin-Biotin example wherein
the absence of the co-crystal compound biotin water molecules solvate the active site forming a fivemembered ring of water molecules that very closely mimics the interactions formed by biotin in the same
space.

5.2.1 The methods used to define pharmacophore features based on water
The work on this study accomplished through a collaborative effort with Dr. Art Cho, his graduate students
Sang Won Jung at Korea University. We shared the responsibilities of testing our pharmacophore feature
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selection criteria. The final virtual screening results presented in section 5.2.2 were the results of screens
performed by our collaborators, however, throughout the course of this study, both institutes produced
screening data that were used to determine the selection criteria methods that define the Water Based
Pharmacophore.
We utilized hydration site analysis on MD trajectories generated using the methods described in the
introductory sections of this chapter to assess discrete water sites as potential water based
pharmacophore features. The Water Based Pharmacophore method that we generated is a selection and
differentiation scheme that assesses each water site defined by HSA as a potential pharmacophore
feature based on its solvent structural and thermodynamic properties. Specifically, the structural and
thermodynamic properties of water in these sites were evaluated to determine whether the site is
significant and should be included as a feature and if so, what type of feature it should be (hydrophobic,
hydrogen bond donor, hydrogen bond acceptor, etc). We developed the water-based pharmacophore site
selection criteria workflow described in figure 27 below through an iterative testing approach whereby
physically intuitive choices such as hydration sites that donate hydrogen bonds to the surface should be
considered a hydrogen bond donor feature and iteratively adjusting the population density required to
flag a site as this type of feature. Ultimately, the methodology described by these works in collaboration
with Dr. Cho and his group in Korea University can be summarized roughly as follows: hydration sites were
considered hydrogen bond donors or acceptors if their donor/acceptor population exceeded 50%,
hydration sites were considered hydrophobic if said sites were found to be energetically unfavorable
relative to bulk water, hydrophobic sites were labeled aromatic if they occupied active site space with an
open surface area determined through Sitemap82 calculations, and donor/acceptor sites were labelled as
positive/negative if said sites were found to be energetically favorable relative to bulk water in addition
to their hydrogen bond population criteria.
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Figure 27. Scheme documenting the process of determining 6 water pharmacophore features.

5.2.2 Virtual Screening results
To validate the Water Based Pharmacophore site selection criteria discussed in the previous section virtual
screening experiments were conducted with WBP generated for seven targets from the Directory of
Useful Decoys (DUD) (table 9).
Table 9. Targets and DUD sets for enrichment studies

These seven targets were selected based on their variable results in the initial DUD screening study
performed with Dock383 with solvent-excluded volume (SEV) ligand desolvation84, where ligand
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conformations were generated with OpenEye’s Omega85, with 200 steps of simplex minimization to pose
and score ligands.. When screened using the WBP features defined using the criteria described in the
scheme above five of the seven systems showed improved enrichment relative to docking with Dock3
(blue highlighted rows table 10). We applied the pharmacophore based virtual screening software PHASE
to develop LBP, WBP, and search compound databases while evaluating enrichment, which applies a treebased partitioning algorithm to search ligand configurations in three dimensional space86,87.
Table 10. Enrichment analysis results using DUD sets for 7 targets by (a) water-based pharmacophore screening
and (b) docking. A result of ‘-’ indicates that too few samples were returned from screening to evaluate at that
ranking percentage. Entries shaded in blue denote targets in which water-pharmacophore outperformed docking.

The ‘Model’ column describes the Pharmacophore model features that were defined using the WBP
method where: D = Hydrogen-bond Donor feature, A = Hydrogen-bond Acceptor feature, H = Hydrophobic
feature, R = Aromatic feature, and N = Negatively charged feature.

These results suggest that the WBP methodology described in these works can be applied in a virtual
screening manner with success.
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Androgen Receptor (AR)
Androgen Receptor (AR) is a nuclear receptor which consists of three domains: an N-terminal domain,
DNA-binding domain (DBD), and ligand binding domain (LBD). When androgens bind to the LBD then AR
binds with DNA in the form of a homodimer to regulate gene expression. AR is involved in a wide variety
of physiological processes, especially control of male sexual differentiation. Since abnormality in AR
function can lead to prostate cancer or benign prostatic hyperplasia (BHP), AR is an important drug
target.88,89 In this work we used PDB structure 1XQ2 with co-crystal compound metribolone (R1881).
Metribolone is a synthetic orally available anabolic-androgenic steroid (AAS) and is a derivative of
nandrolone. Nandrolone is among the most widely used AAS worldwide discovered in 1950's.90
Metribolone was first described in 1965, studied as a potential treatment for breast cancer in the sixties
and seventies, however, it showed signs of hepatotoxicity and was never marketed. Metribolone is the
research industry standard AAS but is not an effective drug compound in its own right.
Metribolone produces seven total pharmacophore features when producing a ligand hypothesis with
PHASE (figure 28a). We identified 11 hydration sites inside the LBD of AR. The WBP procedure identified
four features to be utilized in virtual screening, these features overlapped well with the hypothesis
constructed directly from Metribolone, with the exception of a hydrophobic feature which overlaps with
the cyclic ring (figure 28b). The WBP performed slightly better than the enrichment results presented in
the original DUD study (15.4 against 10.2 for enrichment at 1%). These results suggest that the
pharmacophore described by our WBP approach match the screening results by docking as well as closely
mimic the co-crystal compound.
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Figure 28. (a) Ligand and (b) Water-based pharmacophore model of AR. Green spheres represent hydrophobic
pharmacophore features, light red spheres represent hydrogen bond acceptor features, and light blue spheres
represent hydrogen bond donor features.

Progesterone Receptor (PR)
Progesterone receptor is another nuclear receptor which when combined with progesterone in the
cytosol forms a dimer that then regulates gene expression by binding DNA thereby controlling female
pregnancy and menstruation. Progesterone receptor is a therapeutic target for miscarriage, uterine
cancer, and breast cancer.

91–93

In 1SR7, the PDB structure used in these in silico experiments,

mometasone furoate, a potent steroid agonist, is bound in the ligand binding pocket of PR. Mometasone
furoate is a corticosteroid currently on the market as a therapeutic for inflammation, available as a nasal
spray worldwide.
The pharmacophore hypothesis generated based on mometasone furoate yielded 15 pharmacophore
features and our hydration site analysis produced 18 hydration sites. Our WBP approach generated 6
features, of these except for the hydrophobic feature on the ring group, the remaining five overlap with
the ligand pharmacophore features (Figure 29). Overall the screening with WBP showed a slight
improvement over the initial DUD docking study with Dock3 (21.6 against 10.8 for enrichment at 1%). In
this case, the information gathered from sampling active site water molecules alone matches the cocrystal compound, a well known lead compound for this target.
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Figure 29. (a) Ligand and (b) Water-based pharmacophore model of PR. Green spheres represent hydrophobic
pharmacophore features, light red spheres represent hydrogen bond acceptor features, orange disks represent
aromatic pharmacophore features, and light blue spheres represent hydrogen bond donor features.

Retinoid X receptor alpha (RXR)
Retinoid X receptor is a nuclear receptor and plays a role as a transcription factor controlling various
physiological processes such as cell development, apoptosis, and homeostasis. Ligands that bind RXR are
effective in inhibiting tumor formation, which makes RXR an effective anticancer drug target.

94

In the

structure 1MVC, which is used in this experiment, a synthetic agonist compound BMS649 is bound to the
ligand binding domain (LDB) a crystal structure published in 2002, seven years after RXR was recognized
as a potential cancer therapeutic target. The pharmacophore hypothesis generated with PHASE based on
BMS649 contained 10 features (figure 30). Hydration site analysis yielded 9 hydration sites but they were
all near the opening of the binding site, rather than the LBD. This occurred because the binding site is
hydrophobic and therefore the water molecules in our molecular dynamics trajectory did not penetrate
deep into the LBD. Due to this, the WBP method was unable to produce pharmacophore features. This
system suggests that the WBP methodology may produce poor results in systems where the active site is
strongly hydrophobic.
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Figure 30. Ligand pharmacophore model of RXRα. Green spheres represent hydrophobic pharmacophore features,
light red spheres represent hydrogen bond acceptor features, orange disks represent aromatic pharmacophore
features, dark red spheres represent negatively charged pharmacophore features, and light blue spheres represent
hydrogen bond donor features.

Glucocorticoid Receptor (GR)
The glucocorticoid receptor is a nuclear receptor which binds DNA when combined with steroid hormones
and acts as a transcription factor. It is directly involved in glucose homeostasis, bone turnover, cell
differentiation, lung maturation, and inflammation. Abnormality in GR can cause Cushing's syndrome,
autoimmune diseases, and various kinds of cancer and thus has been studied as an important therapeutic
target.

95–97

The structure used in this experiment (PDB 1M2Z) is bound to the co-crystal compound

dexamethasone in the LBD. This structure was solved in the early 2000's after ten years of extensive study
regarding this potential target. When evaluated with PHASE dexamethasone produces 13 pharmacophore
features (figure 31). Hydration site analysis produced 19 hydration sites, from which 4 WBP features were
generated (figure 31b). In an enrichment study, the WBP model yielded significantly improved enrichment
results compared to screening with Dock3 in DUD (19.4 against 5.2 for enrichment at 1%).

75

Figure 31. (a) Ligand and (b) Water-based pharmacophore model of GR. Green spheres represent hydrophobic
pharmacophore features, light red spheres represent hydrogen bond acceptor features, and light blue spheres
represent hydrogen bond donor features.

Peroxisome Proliferator-Activated Receptor Gamma (PPARγ)
Peroxisome proliferator-activated receptor gamma is a nuclear receptor, which controls fatty acid storage
and glucose metabolism. It’s functionality as a nuclear receptor relies on forming a heterodimer with
retinoid X receptor (RXR). It has been implicated in a number of pathologies such as obesity, diabetes,
atherosclerosis, and cancer. 98–100 The PDB structure utilized in our in silico study was code 1FM9, which
is bound to co-crystal compound α-aryloxyphenylacetic acid, which is a PPARγ agonist. PHASE produced
10 pharmacophore features based on the co-crystal compound (figure 32). Hydration site analysis
produced 25 hydration sites and from these 25 sites, six WBP features were selected (figure 32). In the
original screening study with Dock3 on the DUD database no active compounds were found in the top 1%,
however, our WBP method was able to identify 8 active compounds in the top 1%. We believe that the
screening by docking struggled with this system due to the relatively large size of the binding site,
however, the WBP feature implicates important interactions for binding with the receptor leading to
better screening results.
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Figure 32. (a) Ligand and (b) Water-based pharmacophore model of PPARγ. Green spheres represent hydrophobic
pharmacophore features, light red spheres represent hydrogen bond acceptor features, orange disks represent
aromatic pharmacophore features, dark red spheres represent negatively charged pharmacophore features, and
light blue spheres represent hydrogen bond donor features.

Poly (ADP-ribose) polymerase (PARP)
Poly (ADP-ribose) polymerase is a nuclear enzyme, which plays an important role in DNA damage repair
and has been implicated as a potential therapeutic for cancer. The inhibition of PARP in tumor cells can
strengthen the effect of radiotherapy and DNA-targeted chemotherapy.

101

Our hydration site analysis

revealed 36 hydration sites, which was considerably more than our other targets. PHASE produced 8
pharmacophore features based on the co-crystal compound (figure 33a) and our WBP model identified 5
features (figure 33b). In enrichment studies, docking failed to select active ligands at all levels, similar to
PPARγ this failure may be explained by observing that the binding site is significantly larger than a usual
“drug-like” ligand and therefore differentiating the actual actives from decoys becomes more difficult. On
the other hand, the water-pharmacophore performed rather well, achieving an enrichment factor of 22.6
at 1%.
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Figure 33. (a) Ligand and (b) Water-based pharmacophore model of PARP. Green spheres represent hydrophobic
pharmacophore features, light red spheres represent hydrogen bond acceptor features, orange disks represent
aromatic pharmacophore features, and light blue spheres represent hydrogen bond donor features.

Acetylcholinesterase (AChE)
Acetylcholinesterase is an enzyme that hydrolyzes the neurotransmitter acetylcholine. It is involved in
synaptic transmission and thus is an important therapeutic target for neurodegenerative diseases such as
Alzheimer’s disease.102 The PDB structure 4EY7, used in our experiment, is bound with donepezil, which
is used to treat the symptoms of Alzheimer’s disease for the past 13 years. Research on donepezil began
in 1983 and was eventually marketed by Pfizer in 1996. PHASE produced 9 ligand pharmacophore features
based on donepezil (figure 34a). Hydration site analysis found 43 hydration sites and the WBP algorithm
produced 6 features (figure 34b).
In this case, our water pharmacophore did not enrich as well as docking with Dock3 (24.3 against 3.7 at
1%). This poor performance by the water pharmacophore is probably due to the fact that the binding site
is long and narrow, which makes the pharmacophore sensitive to exact geometries that the WBP method
may not directly describe.
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Figure 34. (a) Ligand and (b) Water-based pharmacophore model of AChE. Green spheres represent hydrophobic
pharmacophore features, light red spheres represent hydrogen bond acceptor features, orange disks represent
aromatic pharmacophore features, dark blue spheres represent positively charged pharmacophore features, and
light blue spheres represent hydrogen bond donor features.

5.2.3 Future computational avenues
After this initial WBP study began further improvements to our internal STM methods had been
developed, both in HSA and GIST. Specifically, the novel focus placed on local water structure that
characterized active site waters as having either frustrated or enhanced local structure relative to bulk
may provide valuable insights into pharmacophore feature identification. Consideration of hydrogen bond
populations and local water structure provides an avenue to describe directionality acceptor. The local
water structure quantified with HSA and GIST can also be used to further delineate the importance of
WBP features, e.g. a hydrophilic feature which contains frustrated local water structure (poor hydrogen
bond contacts with neighboring water molecules), represents a readily displaceable active site water,
whereas enhanced local water structure in the same context may suggest a more complex
pharmacophore feature may be required. These metrics can also be used to incorporate water molecules
as bridging interactions between the potential screened compounds and the active site surface, improving
the directionality of described acceptor and donor features respectively and scanning an enlarged
chemical space.
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To validate the WBP methodology in a drug design context a robust retrospective analysis should be
performed that demonstrates that the pharmacophores generated lead to both enrichment and
potentially the screening of novel chemical space. These validation studies will be performed using the
full DUD-E dataset in an iterative process whereby pharmacophore feature selection criteria are scanned
for optimized thresholds against a training subset of the DUD-E systems and these optimized criteria are
then used to test against the remaining DUD-E systems. The generation of these training and test sets of
DUD-E systems and their associated active and decoys will be performed with random selection,
iteratively. One potential issue with randomly assigning DUD-E systems to either training or test sets lies
in the structural and functional similarity that can be found among several DUD-E systems. We will avoid
contaminating the training and test sets with biased results from these similarities by first clustering target
systems based on structural similarity in their active sites and perform the randomized set selection only
on the representative cluster system. The results from this validation study will be optimized WBP criteria
with averaged training and test set enrichment quantities that can be used to evaluate the utility of this
methodology in a drug design project setting.
Finally, the development of a WBP provides a valuable avenue for defining pharmacophore features that
can be used in virtual screening in the absence of known binders, however, in many cases, the target of
interest in a drug design study will have known binders associated with it. To fully leverage all of the data
available when building a model it would be logical to incorporate WBP features with Ligand-Based
Pharmacophore (LBP) features. In this case, the incorporation of active site water structure and
thermodynamic data can be used to define novel pharmacophore features that the LBP may not define,
redefine the feature types that are mapped with LBP methods, or to reweight existing LBP features. The
inclusion of both ligand and active site water structural information may provide an avenue to further
improve the virtual screening of compound databases and will be discussed further in the next subsection.
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The future studies outlined in this section are designed to take the functional WBP virtual screening
methodology from the initial validation against retrospective datasets to prospective drug design project
application. Finally, in order to validate the application of these pharmacophore methods on a prospective
project will be tested on a relevant drug target by screening against the enamine purchasable compound
database to prospectively identify novel binders.

Incorporation of ligand information into WBP
An attractive method to improve the water-based pharmacophore methodology involves the
development of a novel method wherein ligand and water information are both applied to developing a
pharmacophore hypothesis. Here we discussed the methods developed in our previous work to
differentiate water-based pharmacophore features, the methods to develop ligand based
pharmacophores are well known in the literature and such methods have been incorporated directly into
established CADD software packages such as Maestro and MOE. Ligand-based pharmacophore hypothesis
can be derived from either a single known binder or several simultaneously. A pharmacophore based on
a single known binder can be used to scan compound databases to find other compounds with similar
structural features, typically the use of multiple known binders is preferred due to the defined
pharmacophore features more generally describing how binding to the target protein occurs. Regardless
of the number of known binders in use the ligand-based pharmacophore methodologies do not explicitly
consider the water or protein structure. Therefore, the incorporation of water-based pharmacophore
features into a ligand-based pharmacophore improves consideration of active site structure, including
regions of the active site that the available known binders do not occupy. Importantly, this improvement
in active site coverage works both ways in that known binders may occupy regions of protein active sites
where water does not as is the case of the retinoic X receptor case study discussed above, where hydration
sites were not resolved for its hydrophobic active site. In this case, the regions where water was not found
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in high density are occupied by the co-crystal compound. Therefore, the fusion of ligand and water-based
pharmacophore features can be used to describe the binding behavior of ligands in this target active site.
Generally, the ligand and water-based pharmacophore methodology will rely on defining features using
both approaches in tandem and then selecting a subset of both to define a final pharmacophore. The
optimal site selection and definition criteria will require a full-scale investigation to determine, however
in the case of receptors where water or ligand-based pharmacophores alone are unable to define a
sufficient number of features to scan a compound database the simplistic combinations of features from
both methods provides a means to define an initial pharmacophore. In the retinoic X receptor case
described above, this approach can be used to create a ligand hypothesis based on the co-crystal
compound to combine with features from the water-based pharmacophore to create a functional
pharmacophore. This simplistic hybrid pharmacophore contains a sufficient number of features to enable
database screening with an initial scan of the DUD database returning an enrichment factor of 3.5, a
significant improvement over the water-based pharmacophore method alone.
An initial strategy for combining ligand and water-based pharmacophore methodologies should attempt
to distill pertinent information from both sources. Both ligand and water-based approaches provide
information regarding whether a feature is hydrophobic or hydrophilic as well as the directionality of said
hydrophilic features with regards to the active site surface. When both methods agree on a
pharmacophore feature it should be kept as is, when both methods disagree, however, a selection
criterion must be developed to determine the final feature type.

Refine Water Based Pharmacophores
The water-based pharmacophore methodology described here had been established prior to the
development of further active site water structure and thermodynamic mapping quantities in SSTMap.
The additional metrics defined in SSTMap, such as measures of local water structure, enable improved
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metrics for defining water pharmacophore features. A revamped study aimed at developing improved
water-based pharmacophore criteria may redefine the site selection scheme. This criterion should
determine the final feature type based on local active site structural features, which will likely influence
the result of the water-based pharmacophore feature type.

5.2.4 Water Based Pharmacophore Final remarks
In this work, we demonstrated the feasibility of generating pharmacophore models based purely on the
receptor structure by probing the protein binding-site surface with explicit water molecular dynamics
simulations. We have introduced a method to construct the water-based pharmacophore and
demonstrated that such pharmacophore is able to explore chemical space that is explored using more
traditional ligand-based approaches. We have further demonstrated that the water pharmacophore can
be used for virtual ligand screening processes with a performance that compares well with established
docking methods shown by enrichment studies. Our water pharmacophore methodology selects feature
sites based on thermodynamic criteria, therefore selected sites are more likely to be meaningful
interaction features than random selection. The information the water-based approach provides can be
incorporated into existing ligand-based pharmacophore construction schemes. This technique could also
function as a standalone approach when known binder data is lacking. We envision that introducing
localized solvation thermodynamics through Grid Inhomogeneous Solvation Theory13 or hydration site
approaches such as WaterMap103 and STOW104 could help assign weights to individual pharmacophore
sites and help improve searching and scoring schemes.
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